266 results on '"Jordan, R."'
Search Results
2. Contributors
- Author
-
Adams, Axel, primary, Affun-Adegbulu, Clara, additional, Al-Rasheed, Rakan S., additional, Alaska, Yasser A., additional, Aldawas, Abdulaziz D., additional, Alesa, Saleh Ali, additional, Alexander, George A., additional, Alhadhira, Abdullah Ahmed, additional, Alhajjaj, Fahad Saleha, additional, Alhazmi, Hazem H., additional, Alhussaini, Zainab Abdullah, additional, Aljerian, Nawfal, additional, Aljohani, Majed, additional, AlKhaldi, Khaldoon H., additional, Alkhattabi, Eyad, additional, Allen, Bryant, additional, Almand, Austin, additional, Alnoaimi, Moza M., additional, Alotaibi, Mohammad, additional, Alpert, Evan Avraham, additional, Alrusayni, Yasir A., additional, Alshammari, Mai, additional, Alsulimani, Loui K., additional, Amanullah, Siraj, additional, Anderson, Arian, additional, Arastehmanesh, David, additional, Ardalan, Ali, additional, Argote-Araméndiz, Killiam A., additional, Artenstein, Andrew W., additional, Bailey, Olivia E., additional, Baker, Russell, additional, Balsari, Satchit, additional, Banner, Gregory T., additional, M, Fermin Barrueto, additional, Bartels, Susan A., additional, Baugh, Joshua J., additional, Berg, Frederic, additional, Bhola, Vijai, additional, Binder, William, additional, Bortolin, Michelangelo, additional, Bounes, Vincent, additional, Bouton, Michael, additional, Brown, Natasha, additional, Jr, Frederick M. Burkle,, additional, Burnett, Lynn Barkley, additional, Burns, Michele M., additional, Sr, Nicholas V. Cagliuso,, additional, Cahill, John, additional, Callaway, David W., additional, Caneva, Duane C., additional, Cattamanchi, Srihari, additional, Caycedo, Alejandra, additional, Cetaruk, Edward W., additional, Chacko, Sneha, additional, Chang, James C., additional, Chiang, Crystal, additional, Chiu, David T., additional, Ciottone, Gregory R., additional, Ciottone, Jonathan Peter, additional, Ciottone, Melissa A., additional, Ciottone, Robert A., additional, Ciottone, Robert G., additional, Ciottone, Vigen G., additional, Clark, Alexander, additional, Clark, Jonathan, additional, Conley, Sean P., additional, Cono, Joanne, additional, Cooper, Arthur, additional, Cormier, Scott B., additional, Court, Michael F., additional, Cunningham, Cord W., additional, Czarnecki, Fabrice, additional, Davis, Supriya, additional, Davis, Timothy E., additional, DeMers, Gerard, additional, Dilling, Sharon, additional, Djalali, Ahmadreza, additional, Donahoe, Timothy, additional, Donahue, Joseph, additional, Dresser, Caleb, additional, Dylik, Jason, additional, Easter, Benjamin, additional, Eastman, Alexander, additional, Ebbeling, Laura, additional, Emetarom, Chigozie, additional, Eyal, Nir, additional, Eyre, Andrew J., additional, Freeman, David J., additional, Friedman, Franklin D., additional, Fritz, Christie, additional, Fung, Frederick, additional, Gallahue, Fiona E., additional, Garbern, Stephanie Chow, additional, Gebhart, Mark E., additional, Gluckman, William A., additional, Goolsby, Craig, additional, Gougelet, Robert M., additional, Granholm, Fredrik, additional, Greenough, P. Gregg, additional, Grimes, Jennifer O., additional, Grosse, Steve, additional, Grossman, Shamai A., additional, Jr, John T. Groves, additional, Guidotti, Tee L., additional, Guo, George, additional, Haessler, Sarah, additional, Hall, Matthew M., additional, Hardin, John W., additional, Harrell, Mason, additional, Hart, MD, Alexander, additional, Harvey, Melissa, additional, Hertelendy, PhD, Attila J., additional, Hiremath, Nishanth S., additional, Hitchens, Jordan, additional, Holstege, Christopher P., additional, Horne, Simon T., additional, Horng, Steven, additional, Hosin, Amer, additional, House, Hans R., additional, Ingrassia, Pier Luigi, additional, Issa, Fadi S., additional, Jacoby, Irving “Jake”, additional, Jaiswal, Rajnish, additional, Jay, Gregory, additional, Jenkins, J. Lee, additional, Joseph, Josh W., additional, Kappler, Shane, additional, Keim, Mark E., additional, Kelman, Julie, additional, Ketterer, Andrew R., additional, Khan, Anas A., additional, Kharel, Ramu, additional, Kharod, Chetan U., additional, Kirsch, Thomas D., additional, Knopov, Anita, additional, Kravitz, Max, additional, Lee, J. Austin, additional, Lemery, Jay, additional, Leventhal, Evan L., additional, Loughlin, Jesse, additional, Ludy, Stephanie, additional, Maguire, Brian J., additional, Mahon, Selwyn E., additional, Maniscalco, Paul M., additional, Manners, Philip, additional, Marcus, Leonard Jay, additional, Margus, Colton, additional, Masri, Taha M., additional, Matthews, Jeff, additional, McKay, Sean D., additional, McKinney, Zeke J., additional, McLellan, Robert K., additional, McNulty, Eric J., additional, Mehkri, Faroukh, additional, Mehta, Mandana, additional, Mendelsohn, Rebecca A., additional, Merin, Ofer, additional, Milsten, Andrew, additional, Molé, Dale M., additional, Molloy, Michael Sean, additional, Morelli, Ilaria, additional, Mothershead, Jerry L., additional, Mulhern, John, additional, Mullendore, Nicole F., additional, Musisca, Nicholas J., additional, Naganathan, Sonya, additional, Nathanson, Larry A., additional, Nelson, Erica L., additional, Nelson, Lewis S., additional, Newbury, Bradford A., additional, Newbury, Kimberly, additional, O’Neill, Ansley, additional, Obernier, Robert, additional, Olagnero, Jacopo M., additional, Oostrom-Shah, Leonie, additional, Ordun, Catherine Y., additional, Parazynski, Scott, additional, Park, Andrew J., additional, Partridge, Robert, additional, S, Jeffrey, additional, Phillips, James P., additional, Pinter, Emily, additional, IV, David P. Polatty, additional, Popieluszko, Patrick, additional, Porcaro, William, additional, Proano, Lawrence, additional, Pruitt, Peter B., additional, Qureshi, Moiz, additional, Ragazzoni, Luca, additional, Rashid, Murtaza, additional, Rega, Paul Patrick, additional, Reilly, Michael J., additional, Restuccia, Marc C., additional, Rifino, James J., additional, Robben, Paul M., additional, Rosenblatt, Joy L., additional, Ryan, Kevin M., additional, Rybasack-Smith, Heather, additional, Salway, Richard James, additional, Samo, Daniel, additional, Sanchez, Leon D., additional, Sanford, Shawn M., additional, Sarin, Ritu R., additional, Sarma, Deesha, additional, Schacht, Jesse, additional, Schwind, Valarie, additional, Shapiro, Geoffrey L., additional, Sheehan, Joshua, additional, Shreve, Brian, additional, Simonyan, Grigor, additional, Smith, Devin M., additional, MD, E. Reed Smith,, additional, MA, Jack E. Smith,, additional, Smith, Montray, additional, Smulowitz, Peter B., additional, Snyder, Angela M., additional, Solano, Joshua J., additional, Stenson, Bryan A., additional, Stewart, Charles, additional, Stewart, M. Kathleen, additional, Sullivan, Patrick, additional, Supple, Jared S., additional, Tin, Derrick, additional, Valente, Jonathan Harris, additional, Vear, Kathryn M., additional, Vidyalakshmi, P.R., additional, Vilas, Faith, additional, Vilke, Gary M., additional, Villano, Janna H., additional, Voskanyan, Amalia, additional, Watson, C. James, additional, Weber, Nancy, additional, Weiner, Scott G., additional, Weinstein, Brielle, additional, Weinstein, Eric S., additional, Werner, Jordan R., additional, MD, Roy Karl Werner,, additional, Whitledge, James D., additional, Wiener, Sage W., additional, Wiesner, Lauren, additional, Williams, Kenneth A., additional, Wing, Robyn, additional, Wolfe, Richard E., additional, Wong, Wendy Hin-Wing, additional, Woolard, Robert, additional, Wuthisuthimethawee, Prasit, additional, and Youssef, Nadine A., additional
- Published
- 2024
- Full Text
- View/download PDF
3. Effect of the COVID-19 Pandemic on Monitoring and Control of Cardiovascular Risk Factors and Disparities
- Author
-
Yuan Lu, ScD, John E. Brush, Jr, MD, Yuntian Liu, MPH, Shu-Xia Li, PhD, Jordan R. Asher, MD, MS, and Harlan M. Krumholz, MD, SM
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Published
- 2024
- Full Text
- View/download PDF
4. Patellar Resurfacing Is Not a Risk Factor for Postoperative Patella Baja in Total Knee Arthroplasty
- Author
-
Kade S. McQuivey, MD, Collin Braithwaite, BS, Jordan R. Pollock, BS, M. Lane Moore, BS, Joseph C. Brinkman, MD, Jack Haglin, MD, Roman Austin, BS, Mark J. Spangehl, MD, and Joshua S. Bingham, MD
- Subjects
Patella baja ,Pseudopatella baja ,Total knee arthroplasty ,Orthopedic surgery ,RD701-811 - Abstract
Background: Patella baja is a known complication of total knee arthroplasty (TKA). There is a limited understanding of the association between patellar resurfacing and the incidence of patella baja. We aimed to compare rates of patella baja between unresurfaced and resurfaced patellas in patients undergoing TKA. Methods: A retrospective review of patients who underwent TKA between October 2009 and January 2020 was performed. Patients were included if they had at least one preoperative radiograph and a 1-year follow-up radiograph. Blackburne-Peel index (BPI) and Insall-Salvati ratios (ISRs) were measured on preoperative and 1-year postoperative radiographs and were used to define patella baja vs pseudopatella baja. Statistical analysis was performed using a linear model analysis of variance and the Fisher’s exact test. Results: Three hundred eighteen TKAs were included, with 176 being resurfaced and 142 unresurfaced patellas. Of the resurfaced group, 4% (7/176) had true patella baja, compared to 5.6% (8/142) of the unresurfaced patellas. Of the resurfaced patellas, 8% (14/176) had pseudopatella baja, compared to 7% (10/142) in the unresurfaced group. Patellar resurfacing was not associated with a higher incidence of patella baja (P = .60) or pseudopatella baja (P = .83). Lower preoperative ISRs (P = .04) and BPIs (0.03) were highly predictive of a higher incidence of patella baja post-TKA. Conclusions: Patellar resurfacing in TKA is not associated with a higher incidence of patella baja in TKA when compared to unresurfaced patellas. Lower preoperative ISRs and BPIs are highly predictive of a higher incidence of postoperative patella baja.
- Published
- 2024
- Full Text
- View/download PDF
5. Patient Interest in Quadriceps Autograft Anterior Cruciate Ligament Reconstruction Is Increasing Over Other Autograft Options: A 12-Year Google Trends Analysis
- Author
-
Joseph C. Brinkman, M.D., M. Lane Moore, B.S., Cara Lai, M.D., Sailesh V. Tummala, M.D., Jordan R. Pollock, B.S., Kade S. McQuivey, M.D., Jeffrey D. Hassebrock, M.D., Adam B. Thompson, B.S., and Anikar Chhabra, M.D.
- Subjects
Sports medicine ,RC1200-1245 - Abstract
Purpose: To use Google trends to explore differences in public interest among types of anterior cruciate ligament (ACL) autografts, specifically quadriceps tendon, patellar tendon, and hamstring tendon autografts, between 2008 and 2019. Methods: Data were obtained by querying Google Trends for key terms and phrases for online search data ranging from January 2008 to December 2019. Relative search volumes were created based on searches related to ACL reconstruction with comparative analysis generated for search terms related to quadriceps ACL, patellar tendon ACL, and hamstring ACL autografts. Statistical analysis included linear regression analysis, comparison of quarterly search volume trends over time, and comparison of cumulative annual search volumes for 2008 versus 2019. Results: Linear models for respective search terms were statistically significant for the quadriceps (P < .001) and patellar (P = .007) tendon autograft groups but not the hamstring group (P = .129). The quadriceps autograft group demonstrated a 12-year search volume trend change of 0.56, which was significantly greater than the hamstring (0.07; P < .001) and patellar tendon (0.168; P < .001) groups. There was no significant difference in the trend change between hamstring and patellar tendon groups (P = .20). Percent change in cumulative relative annual search volumes between 2008 and 2019 was 112% for the quadriceps tendon group, 12.9% for the hamstring group, and 18.6% for the patellar tendon group. Conclusions: This study indicates a consistently increasing public interest in quadriceps tendon autograft for ACL reconstruction. The quadriceps autograft group demonstrated a significantly greater 12-year online search volume, greater linear correlation, and larger percent change between 2008 and 2019 compared with patellar tendon or hamstring autograft groups. Clinical Relevance: Awareness of patient perceptions has value in informing shared decision-making, aligning patient expectations, and guiding areas of future research. Each of these has an impact on patient care. Being aware of patient interest and expectations is particularly important in areas with controversial or emerging research.
- Published
- 2024
- Full Text
- View/download PDF
6. Urinary concentrations of phthalate metabolites in relation to preeclampsia and other hypertensive disorders of pregnancy in the environmental influences on child health outcomes (ECHO) program
- Author
-
John D. Meeker, Kristen L. McArthur, Jennifer J. Adibi, Akram N. Alshawabkeh, Emily S. Barrett, Sara G. Brubaker, Jose F. Cordero, Dana Dabelea, Anne L. Dunlop, Julie B. Herbstman, Linda G. Kahn, Catherine J. Karr, Shilpi Mehta-Lee, Thomas G. O'Connor, Sheela Sathyanarayana, Leonardo Trasande, and Jordan R. Kuiper
- Subjects
Environmental sciences ,GE1-350 - Abstract
Background: Phthalate exposure may contribute to hypertensive disorders of pregnancy (HDP), including preeclampsia/eclampsia (PE/E), but epidemiologic studies are lacking. Objectives: To evaluate associations of pregnancy phthalate exposure with development of PE/E and HDP. Methods: Using data from 3,430 participants in eight Environmental influences on Child Health Outcomes (ECHO) Program cohorts (enrolled from 1999 to 2019), we quantified concentrations of 13 phthalate metabolites (8 measured in all cohorts, 13 in a subset of four cohorts) in urine samples collected at least once during pregnancy. We operationalized outcomes as PE/E and composite HDP (PE/E and/or gestational hypertension). After correcting phthalate metabolite concentrations for urinary dilution, we evaluated covariate-adjusted associations of individual phthalates with odds of PE/E or composite HDP via generalized estimating equations, and the phthalate mixture via quantile-based g-computation. We also explored effect measure modification by fetal sex using stratified models. Effect estimates are reported as odds ratios (OR) with 95% confidence intervals (95% CIs). Results: In adjusted analyses, a doubling of mono-benzyl phthalate (MBzP) and of mono (3-carboxypropyl) phthalate (MCPP) concentrations was associated with higher odds of PE/E as well as composite HDP, with somewhat larger associations for PE/E. For example, a doubling of MCPP was associated with 1.12 times the odds of PE/E (95%CI 1.00, 1.24) and 1.02 times the odds of composite HDP (95%CI 1.00, 1.05). A quartile increase in the phthalate mixture was associated with 1.27 times the odds of PE/E (95%CI 0.94, 1.70). A doubling of mono-carboxy isononyl phthalate (MCiNP) and of mono-carboxy isooctyl phthalate (MCiOP) concentrations were associated with 1.08 (95%CI 1.00, 1.17) and 1.11 (95%CI 1.03, 1.19) times the odds of PE/E. Effect estimates for PE/E were generally larger among pregnancies carrying female fetuses. Discussion: In this study, multiple phthalates were associated with higher odds of PE/E and HDP. Estimates were precise and some were low in magnitude. Interventions to reduce phthalate exposures during pregnancy may help mitigate risk of these conditions.
- Published
- 2024
- Full Text
- View/download PDF
7. Trends in co-prescribed opioids and benzodiazepines, non-prescribed opioids and benzodiazepines, and schedule-I drugs in the United States, 2013 to 2019
- Author
-
Shaden A. Taha, Jordan R. Westra, Danyel H. Tacker, Mukaila A. Raji, and Yong-Fang Kuo
- Subjects
Opioids ,Benzodiazepines ,Schedule I drugs ,Drug abuse ,Opioid misuse ,Concomitant use ,Medicine - Abstract
Concurrent opioid and benzodiazepine users are at increased risk of overdose death, compared to opioid-only users. The objective of this study was to understand recent time trends in opioid and benzodiazepine concurrent use, misuse, and schedule-I drug use, and how these differ by age, sex and geographic region. Commercial, United States medical insurance claims data and urine drug test results from 2013 to 2019 were used to study the outcomes of concurrent use (n = 756,258), schedule-I drug use (n = 746,672) and prescription misuse (n = 452,523). Drug use outcomes were studied at quarterly time points for each year.Data analysis included joinpoint regression models to estimate quarterly drug use rates, determined by positive urine tests for corresponding drug categories, and was conducted from November 2021 through January 2022. Concurrent use decreased from 19.3% to 9.8%, misuse generally decreased from 75.6% to 55.1%, and schedule-I use increased from 8.9% to 13.8%, from 2013 to 2019. Concurrent use decreased at greater rates after 2016, after the Centers for Disease Control and Food and Drug Administration guidelines against concurrent use were released, while schedule-I use increased, notably after the 2014 hydrocodone reschedule. This indicates a potential shift from prescription use to non-prescribed drug use, where most affected groups included males, younger individuals, and those residing in Northeastern regions.Study results support public health initiatives focused on policy that increases access to multimodal pain management and substance use disorder management programs—critical steps in preventing patients from seeking non-prescribed drugs for self- medicating due to pain or addiction.
- Published
- 2024
- Full Text
- View/download PDF
8. Personalized 7T fMRI-Guided navigation TMS targeting: Preliminary data of speech-motor cortex in speech perception
- Author
-
Mohammad Daneshzand, Kaisu Lankinen, Jyrki Ahveninen, Qing Mei Wang, Jordan R. Green, Teresa J. Kimberley, and Shasha Li
- Subjects
Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Published
- 2023
- Full Text
- View/download PDF
9. How will climatic warming affect insect pollinators?
- Author
-
Johnson, Meredith G., primary, Glass, Jordan R., additional, Dillon, Michael E., additional, and Harrison, Jon F., additional
- Published
- 2023
- Full Text
- View/download PDF
10. Patients are Most Interested in Which Hip Arthroplasty Approach? A 15-year Google Trends Analysis
- Author
-
M. Lane Moore, BS, MBA, Joseph C. Brinkman, MD, Jordan R. Pollock, BS, MBA, David G. Deckey, MD, Justin L. Makovicka, MD, MBA, and Joshua S. Bingham, MD
- Subjects
Arthroplasty ,Total hip arthroplasty ,Google Trends ,Direct anterior approach ,Public interest ,Orthopedic surgery ,RD701-811 - Abstract
Background: The purpose of this analysis was to assess the public interest in total hip arthroplasty (THA) based on approach by analyzing Google Trends online search volume trends between 2007 and 2021. Methods: Data were obtained by querying the Google Trends online search tool for key terms and phrases relating to anterior, posterior, lateral, and minimally invasive approaches to THA. Data from January 2007 to December 2021 were utilized. Relative search volume (RSV) was generated for each THA approach group based on historical search volume trends in the United States. Results: Over the 15-year period, Google Trends Search Data demonstrated a statistically significant increase (P < .001) in the RSV for all 4 major hip arthroplasty approaches. The growth in public interest for anterior hip arthroplasty was significantly greater than the growth for posterior (P = .02) and minimally invasive hip arthroplasty (P = .02). The difference in RSV growth between lateral and anterior approaches was not significant (P = .88). The average RSV for anterior hip arthroplasty was 59.0, which was significantly greater than the average RSV of all other groups. Conclusions: The anterior approach to hip arthroplasty has demonstrated a consistent and statistically significant increase in RSV over the past 15 years that has outpaced the increases observed in the posterior and minimally invasive approaches. Despite the increase in public awareness and interest for anterior approach hip arthroplasty, it is yet to demonstrate any long-term clinical benefits over other approaches.
- Published
- 2022
- Full Text
- View/download PDF
11. Recurrent heterotopic ossification following open radical nephrectomy
- Author
-
Jordan R. Richards, Ian M. McElree, Joanna Orzel, Mark C. Smith, and Vignesh T. Packiam
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
A 46-year-old male presented with a localized left renal mass and underwent an open radical nephrectomy via a midline incision. He recovered uneventfully and was discharged. After one month he reported persistent incisional pain; CT demonstrated heterotopic bone formation under the fascial closure. He underwent resection of calcified preperitoneal fat. Final pathology revealed benign bone tissue. He received a course of celecoxib. The patient developed recurrence of a smaller calcification. He underwent a second resection and was treated with adjuvant radiation. The patient had improvement of pain and no ossification visualized on CT imaging at 1-year follow up.
- Published
- 2023
- Full Text
- View/download PDF
12. Public Interest in Shoulder Platelet-Rich Plasma Injections Is Increasing: A 10-Year Google Trends Analysis
- Author
-
Joseph C. Brinkman, M.D., Kade S. McQuivey, M.D., Jeffrey D. Hassebrock, M.D., M. Lane Moore, B.S., Jordan R. Pollock, B.S., and John M. Tokish, M.D.
- Subjects
Sports medicine ,RC1200-1245 - Abstract
Purpose: To quantify and analyze public interest trends in platelet-rich plasma (PRP) therapy for shoulder pathology between 2011 and 2020 using Google Trends data. Methods: Google Trends data were queried for online search data ranging from January 2011 to December 2020. Various combinations of terms related to PRP and shoulder pathology were queried. Terms related to corticosteroid therapy in association with shoulder pathology were also generated for comparative analysis. Analyses were performed regarding trends in online search volumes. Results: Linear models were generated to evaluated trends in the volume of online searches for PRP and corticosteroid therapy for shoulder pathology. For both the PRP and steroid groups, linear models showed a statistically significant increase in search volume for the period studied (P < .001). The PRP group showed a significantly greater growth rate than the steroid group (P < .001). There were no statistically significant differences in online search volume when compared between different geographic and socioeconomic locations. Conclusions: This study indicates consistently increasing public interest in PRP injections in the shoulder. The rate of online search volume growth of PRP is significantly greater than that of corticosteroid injections for the period studied. Clinical Relevance: Awareness of patient perceptions has value in informing shared decision making, aligning patient expectations, and guiding areas of future research. Each of these has an impact on patient care. Being aware of patient interest and expectations is particularly important in areas with controversial or emerging research.
- Published
- 2023
- Full Text
- View/download PDF
13. Metatranscriptomics analysis reveals a novel transcriptional and translational landscape during Middle East respiratory syndrome coronavirus infection
- Author
-
Ethan J. Fritch, Wes Sanders, Amy C. Sims, Laura E. Herring, Natalie K. Barker, Athena A. Schepmoes, Karl K. Weitz, Jordan R. Texier, Dirk P. Dittmer, Lee M. Graves, Richard D. Smith, Katrina M. Waters, Nathaniel J. Moorman, Ralph S. Baric, and Rachel L. Graham
- Subjects
Medical microbiology ,Virology ,Transcriptomics ,Science - Abstract
Summary: Among all RNA viruses, coronavirus RNA transcription is the most complex and involves a process termed “discontinuous transcription” that results in the production of a set of 3′-nested, co-terminal genomic and subgenomic RNAs during infection. While the expression of the classic canonical set of subgenomic RNAs depends on the recognition of a 6- to 7-nt transcription regulatory core sequence (TRS), here, we use deep sequence and metagenomics analysis strategies and show that the coronavirus transcriptome is even more vast and more complex than previously appreciated and involves the production of leader-containing transcripts that have canonical and noncanonical leader-body junctions. Moreover, by ribosome protection and proteomics analyses, we show that both positive- and negative-sense transcripts are translationally active. The data support the hypothesis that the coronavirus proteome is much vaster than previously noted in the literature.
- Published
- 2023
- Full Text
- View/download PDF
14. Bilobed flap reconstruction after en-bloc removal of solitary fibrous tumor of the lacrimal sac
- Author
-
Alomi O. Parikh, Diana K. Lee, James T. Gibson, Jordan R. Conger, Maria Sibug Saber, Margaret L. Pfeiffer, and Michael A. Burnstine
- Subjects
Solitary fibrous tumor ,Medial canthus reconstruction ,Ophthalmology ,RE1-994 - Abstract
Purpose: To report a rare case of a solitary fibrous tumor (SFT) of the lacrimal sac and discuss considerations for management of similar cases. Observations: We present the case of a 41-year-old woman who presented with a primary lacrimal sac SFT for which she underwent en-bloc surgical resection. We discuss management options for SFTs and our surgical approach for this case: bilobed flap reconstruction of the medial canthus and inferior orbit. Conclusions: We present an uncommon presentation of a rare tumor and a successful one-stage reconstruction with a bilobed flap.
- Published
- 2023
- Full Text
- View/download PDF
15. A fenestrated, double-barrel technique for proximal reintervention after open or endovascular abdominal aortic aneurysm repair
- Author
-
Jordan R. Stern, MD, Kenneth Tran, MD, Shernaz S. Dossabhoy, MD, Sabina M. Sorondo, MD, and Jason T. Lee, MD
- Subjects
Aortic aneurysm ,Endovascular ,Fenestrated/branched repair ,Surgery ,RD1-811 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Objective: Proximal endovascular reintervention after prior endovascular aortic repair (EVAR) or open abdominal aortic aneurysm repair (OR) can be challenging due to the short distance to the visceral branches. We present a novel solution to allow the use of the commercially available ZFEN device using a double-barrel, kissing-limb technique. Methods: Patients who underwent fenestrated repair for proximal failure after EVAR or OR were identified. The ZFEN device is deployed above the prior graft flow divider. Once the visceral branches are secured, kissing limbs are used to connect with the prior graft limbs. The distal diameter of the standard ZFEN is 24 mm, accommodating two 20 mm components according to the formula 2πDLIMB = πDZFEN + 2DZFEN. Results: Of 235 patients who underwent repair using ZFEN from 2012 to 2021 at a single institution, 28 were treated for proximal failure of prior repairs, with 13 treated using the double-barrel technique (8 EVAR, 5 OR). The distance from the flow divider to the lowest renal artery was 67 ± 24.4 mm (range, 39-128 mm), and the distance to the superior mesenteric artery (SMA) was 87 ± 30.5 mm (range, 60-164 mm). Technical success was 100%. Seven patients had standard ZFEN builds (2 renal small fenestrations, SMA large fen/scallop). The minimum distance to the lowest renal artery and SMA to accommodate a standard ZFEN build was 56 and 60 mm, respectively. Four patients required adjunctive snorkel grafts and two required laser fenestrations. Two patients had gutter leaks at 1 month that self-resolved; one patient developed a late type 1a endoleak. Freedom from reintervention was 90%, 72%, and 48% at 1, 2, and 3 years, respectively. Conclusions: This double-barrel technique allows for distal seal of commercial ZFEN devices into prior open or endovascular repairs with good technical success. Long-term outcomes remain to be quantified.
- Published
- 2023
- Full Text
- View/download PDF
16. Fluorescent pulse-chase labeling to monitor long-term mitochondrial degradation in primary hippocampal neurons
- Author
-
Jordan R. Schneider and Chantell S. Evans
- Subjects
Cell Biology ,Cell culture ,Cell-based Assays ,Metabolism ,Microscopy ,Molecular Biology ,Science (General) ,Q1-390 - Abstract
Summary: The accumulation of dysfunctional mitochondria is a hallmark of neurodegenerative diseases, yet the dynamics of mitochondrial turnover in neurons are unclear. Here, we describe a protocol to monitor the degradation of spectrally distinct, “aged” mitochondrial populations. We describe the preparation and transfection of primary rat hippocampal neuron cultures. We detail a mitochondrial-damaging assay, a SNAP pulse-chase labeling paradigm, and live imaging to visualize the mitochondrial network. Finally, we provide steps to quantify mitochondrial turnover via lysosomal fusion.For complete details on the use and execution of this protocol, please refer to Evans and Holzbaur (2020a). : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.
- Published
- 2022
- Full Text
- View/download PDF
17. Characterizing negative reviews of orthopedic spine surgeons and practices
- Author
-
Joseph C. Brinkman, Jordan R. Pollock, Jaymeson R. Arthur, Jacob Smith, Keldon Lin, and Michael S. Chang
- Subjects
Online ,Physician ratings ,Physician reviews ,Social media ,Quality ,Reimbursement ,Orthopedic surgery ,RD701-811 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Background: Recent evidence suggests that patients prefer subjective and crowd-sourced information over data-driven or quality-based outcomes when choosing a surgeon. Online physician rating and review websites continue to increase in popularity, and over half of patients use them to research physicians. Specifically, Yelp.com is the most frequently utilized online resource by patients. Data regarding the characteristics of negative reviews for spine surgeons and practices is lacking. Methods: Orthopedic Spine surgeons and practices in 8 major US metropolitan regions were surveyed for one-star reviews on Yelp.com. The factors noted in the reviews were recorded and they were classified according to their clinical or nonclinical nature. Reviews were also subclassified into nonsurgical or surgical episodes of care. Results: A total of 6,286 Yelp reviews were discovered, 671 (10.6%) of which were rated one-star. The majority of negative reviews (76.4%) were from patients who did not report surgery by the surgeon or practice. Of all comments, 491 (77.6%) related to nonclinical complaints. The most common factors noted in negative reviews were related to bedside manner, rude or unprofessional staff, and wait time. Conclusion: Choosing a surgeon is a complex process for patients. The large majority of negative reviews were related to nonclinical issues such as poor bedside manner or rude staff and most of these were written by patients that did not undergo a surgical procedure. This may explain the large discrepancy that has been observed between quality metrics and online crowd-sourced reviews. Paying attention to these nonclinical factors may represent the most feasible and valuable targets to improve a surgeon's practice and attract future patients.
- Published
- 2022
- Full Text
- View/download PDF
18. Increasing severity of anemia is associated with poorer 30-day outcomes for total shoulder arthroplasty
- Author
-
Matthew K. Doan, BS, Jordan R. Pollock, BS, M. Lane Moore, BS, Jeffrey D. Hassebrock, MD, Justin L. Makovicka, MD, MBA, John M. Tokish, MD, and Karan A. Patel, MD
- Subjects
Anemia ,Shoulder ,Arthroplasty ,Degenerative disease ,Osteoarthritis ,Outcomes ,Orthopedic surgery ,RD701-811 ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Background: Total shoulder arthroplasty (TSA) has increased in utilization over the past several decades. Anemia is a common preoperative condition among patients undergoing TSA and has been associated with poorer outcomes in other surgical procedures. To the best of our knowledge, no study has analyzed the association between anemia severity and TSA outcomes. Therefore, the purpose of this study is to determine the effects that increasing severity of anemia may have on the postoperative outcomes in patients receiving primary TSA. Methods: A retrospective analysis was performed using the American College of Surgeons National Surgery Quality Improvement Project database from the years 2015 to 2018. Current Procedure Terminology code 23472 was used to identify all primary TSA procedures recorded during this time frame. Patients with greater than 38% preoperative hematocrit (HCT) were classified as having normal HCT levels. Patients with HCT values between 33% and 38% were classified as having mild anemia. All patients with less than 33% HCT were classified as having moderate/severe anemia. Patient demographic information, preoperative risk factors, and postoperative outcomes were compared among the 3 cohorts. A multivariate logistic regression including demographic factors and comorbidities was performed to determine whether increasing severity of anemia is independently associated with poorer postoperative outcomes. Results: Of the 15,185 patients included in this study, 11,404 had normal HCT levels, 2962 patients were mildly anemic, and 819 patients had moderate to severe anemia. With increasing severity of anemia, there was an increased average hospital length of stay (1.6 vs. 2.1 vs. 3.0 days, P
- Published
- 2021
- Full Text
- View/download PDF
19. Top-100 Most-Cited Sports-Related Concussion Articles Focus on Symptomatology, Epidemiology, and Demographics
- Author
-
Kade S. McQuivey, M.D., M. Lane Moore, B.S., Jordan R. Pollock, B.S., Jeffrey D. Hassebrock, M.D., Karan A. Patel, M.D., and Anikar Chhabra, M.D.
- Subjects
Sports medicine ,RC1200-1245 - Abstract
Purpose: To analyze the top-100 cited articles on sports-related concussions together with a bibliometric analysis to determine citations by year, level of evidence, study design, and several other factors related to the top referenced articles in sports concussions. Methods: The Clarivate Analytics Web of Knowledge database was used to gather data using Boolean queries to capture all possible iterations of sports-related concussion research. Articles were organized in descending order based on the number of citations and included or excluded based on relevance to concussion. Collected information included author name, publication year, country of origin, journal name, article type, study focus, and the level of evidence. Results: The top-100 articles were cited 31,197 times with an average of 312.0 citations per publication. More than one half were published in 2006 or later (52). Cohort studies and descriptive articles were the most prevalent study types (22 each). Studies with Level V evidence were the most common (33). The most common areas of study were symptomatology (short term, long term) with 17 articles, followed by epidemiology/demographics with 16 articles. The least common area of study was concussion prevention (2 articles), followed by management/treatment, diagnostics (labs, imaging) with 4 articles each. Conclusions: We identified the most influential studies in sports-related concussion based on number of citations and citation density. A majority of these articles were published in the United States after 2006 and are most commonly cohort studies (Level IV evidence) and descriptive articles (Level V evidence). Current research focuses most heavily on the symptomatology and epidemiology/demographics of sports concussion. Clinical Relevance: This study serves to identify the most influential articles in sports-related concussion and identify research topics with general deficiencies within the field of sports-related concussion research.
- Published
- 2021
- Full Text
- View/download PDF
20. Orthopaedic Foot and Ankle Surgery Fellowship Directors Are Typically White Men in Their Early 50s With Strong Achievements in Research
- Author
-
Muhammad Ali Elahi, B.S., M. Lane Moore, B.S., Matthew K. Doan, B.S., Jordan R. Pollock, B.S., Jeffrey D. Hassebrock, M.D., Justin L. Makovicka, M.D., M.B.A., Joseph C. Brinkman, M.D., and Karan A. Patel, M.D.
- Subjects
Sports medicine ,RC1200-1245 - Abstract
Purpose: To determine the objective characteristics of orthopaedic foot and ankle fellowship directors (FDs) by concentrating on the demographic characteristics, academic background, institutional history, research experience, and professional affiliations of these leaders. Methods: Data for each FD were collected by searching institutional biographies, personal websites, or publicly available curricula vitae. Data collection included the following variables: age, sex, race/ethnicity, previous training institutions, residency and fellowship graduation years, advanced degrees, military affiliation, institutional loyalty, year hired, FD career timeline, total number of publications, total number of citations, and h-index. Results: Of the 47 FDs, 44 (93.6%) were men and 3 (6.4%) were women. The mean age was 50.8 ± 9.4 years. Most orthopaedic foot and ankle FDs were white (n = 42, 89.4%), followed by Asian (n = 4, 8.5%) and black or African American (n = 1, 2.1%). The mean Scopus h-index, total number of publications, and total number of citations for all foot and ankle FDs were 13.3 ± 9.5, 47.5 ± 45.8, and 898.1 ± 1,040.3, respectively. Among all foot and ankle FDs, the mean tenure in the FD position was 5.8 ± 4.6 years. Conclusions: Orthopaedic foot and ankle FDs are primarily white men in their 50s, with minimal female and minority representations. These FDs are distinguished by their high level of research productivity. Additionally, orthopaedic foot and ankle training backgrounds seem to play an important role, given that most of the appointed FDs trained in only a few select programs. Clinical Relevance: This study outlines some of the most important characteristics among foot and ankle FDs and identifies important disparities within this population of leaders that may have detrimental effects on the field.
- Published
- 2021
- Full Text
- View/download PDF
21. Women and Men National Collegiate Athletic Association Ice Hockey Players Were Similarly Likely to Suffer Lumbar Spine Injuries
- Author
-
Anna S. Jenkins, B.S., Jordan R. Pollock, B.S., Sailesh V. Tummala, M.D., Joseph C. Brinkman, M.D., Merritt C. Kropelnicki, B.S., Justin L. Makovicka, M.D., M.B.A., Jeffrey D. Hassebrock, M.D., and Anikar Chhabra, M.D.
- Subjects
injury ,ice hockey ,lumbar spine ,NCAA ,Sports medicine ,RC1200-1245 - Abstract
Purpose: To describe and compare the epidemiology of lumbar spine injuries (LSIs) in women’s and men’s ice hockey during the 2009-2010 to 2013-2014 academic years and to investigate sex-specific differences, using data from the National Collegiate Athletic Association (NCAA) Injury Surveillance Program (ISP) database. Methods: The incidence and characteristics of LSIs were identified utilizing the NCAA ISP. Rates of injury were calculated as number of injuries divided by total number of athlete exposures (AEs). AEs were defined as any student participation in one NCAA-sanctioned practice or competition. Incidence rate ratios (IRRs) were calculated to compare rates of injury between season, event type, mechanism, injury recurrence, and time lost from sport, and injury proportion ratios (IPRs) were calculated to examine the differences in injury rates between men and women. Results: There were a total of 165 LSIs from an average of 10 and 19 women’s and men’s teams, respectively, calculated to 1,254 LSIs nationally. Women were 2.48 times more likely to suffer a noncontact injury than men (95% CI: 1.33-4.61), whereas men were more likely than women to suffer contact LSIs (IPR: .51 [95% CI: .28-.92]). In Divisions II and III, women were 6.64 (95% CI: 4.14-10.64) and 1.28 (95% CI: 1.12-1.46) times more likely to suffer LSIs than men, respectively. Conclusions: Women and men were similarly likely to suffer an LSI, but sex-specific differences existed in a mechanism of injury and likelihood of injury within NCAA Divisions.
- Published
- 2021
- Full Text
- View/download PDF
22. Orthopaedic Group Practice Size Is Increasing
- Author
-
Jordan R. Pollock, B.S., M. Lane Moore, B.S., Jacob S. Hogan, B.S., Jack M. Haglin, M.D., M.S., Joseph C. Brinkman, M.D., Matthew K. Doan, B.S., and Anikar Chhabra, M.D.
- Subjects
Sports medicine ,RC1200-1245 - Abstract
Purpose: To analyze recent trends in orthopaedic surgery consolidation and quantify these changes temporally and geographically from 2012 to 2020. Methods: We performed a retrospective cross-sectional analysis of orthopaedic surgeon practice size in the United States using 2012 and 2020 data obtained from the Physician Compare database. Results: Although we observed an increase from 21,216 unique orthopaedic surgeons in 2012 to 21,553 in 2020 (1.6% increase), the number of practices experienced a large decrease from 7,299 practices in 2012 to 5,829 in 2020 (20.1% decrease). The proportion of orthopaedic surgeons working in solo practices decreased from 13.2% (2,790) in 2012 to 7.4% (1,595) in 2020, and the proportion of orthopaedic surgeons working in groups sized 2 to 24 decreased from 35.3% (7,482) in 2012 to 22.2% (4,775) in 2020. In contrast, groups sized 25 to 99 have grown from 20.7% (4,387) of all orthopaedic surgeons to 23.4% (5,048) in 2020. Groups sized 100 to 499 have increased from 16.9% (3,593) in 2012 to 24.1% (5,190) in 2020, whereas groups sized 500 or greater have grown from 14% (2,964) in 2012 to 22.9% (4,945) in 2020. The number of unique group practices showed a significant decrease in the number of solo groups, which comprised 43.8% (3,200) of the total number of individual practices in 2012, decreasing to 32% (1,886) in 2020. All other groups increased in number and proportionally from 2012 to 2020. Conclusions: This study shows that over the period from 2012 to 2020, there has been a substantial trend of orthopaedic surgeons shifting to increasing practice sizes, potentially indicating that more orthopaedic surgeons are working for large health care organizations rather than small independent practices. Clinical Relevance: The impact of these changes should be examined to determine large-scale effects on patient care, payment models, access, and outcomes, along with physician compensation, lifestyle, and satisfaction.
- Published
- 2021
- Full Text
- View/download PDF
23. Urinary specific gravity measures in the U.S. population: Implications for the adjustment of non-persistent chemical urinary biomarker data
- Author
-
Jordan R. Kuiper, Katie M. O'Brien, Kelly K. Ferguson, and Jessie P. Buckley
- Subjects
Bias ,Creatinine ,Specific gravity ,Urinary dilution ,Non-persistent chemicals ,Environmental sciences ,GE1-350 - Abstract
Background: Urinary biomarkers are often corrected for sample dilution using creatinine, which is influenced by sociodemographic factors and certain health conditions. It is unknown whether these factors similarly influence specific gravity. Objectives: To identify predictors of specific gravity and creatinine and compare methods for correcting estimated chemical concentrations for sample dilution using these measures. Methods: We assessed predictors of urinary specific gravity and creatinine among NHANES 2007–2008 participants (n = 7257). We corrected concentrations of mono-n-butyl phthalate (MnBP) for dilution using two methods, each applied to both specific gravity and creatinine: correction using a sample mean of the dilution indicator (i.e., specific gravity or creatinine) and covariate-adjusted standardization. We compared distributions and assessed the agreement of uncorrected or corrected concentrations visually using Bland-Altman plots and statistically by Kendall’s τa. We stratified all analyses by age category (i.e., 6–19 or 20+ years of age). Results: Gender, race/ethnicity, body mass index, and height were associated with urinary specific gravity and creatinine. Distributions of corrected MnBP concentrations were comparable for both methods and dilution indicators, but agreement between methods was greater for specific gravity. Additionally, specific gravity- and creatinine-corrected MnBP concentrations had slightly greater agreement with each other when corrected using a covariate-adjusted standardization method. Discussion: Specific gravity, like creatinine, is associated with sociodemographic and body composition variables. Accounting for these factors as part of the dilution correction method may be important to minimize bias.
- Published
- 2021
- Full Text
- View/download PDF
24. Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosis
- Author
-
Catherine R. Armbruster, Christopher W. Marshall, Arkadiy I. Garber, Jeffrey A. Melvin, Anna C. Zemke, John Moore, Paula F. Zamora, Kelvin Li, Ian L. Fritz, Christopher D. Manko, Madison L. Weaver, Jordan R. Gaston, Alison Morris, Barbara Methé, William H. DePas, Stella E. Lee, Vaughn S. Cooper, and Jennifer M. Bomberger
- Subjects
Pseudomonas aeruginosa ,cystic fibrosis ,sinus ,pathoadaptation ,biofilm ,hybrid assembly ,Biology (General) ,QH301-705.5 - Abstract
Summary: Pseudomonas aeruginosa notoriously adapts to the airways of people with cystic fibrosis (CF), yet how infection-site biogeography and associated evolutionary processes vary as lifelong infections progress remains unclear. Here we test the hypothesis that early adaptations promoting aggregation influence evolutionary-genetic trajectories by examining longitudinal P. aeruginosa from the sinuses of six adults with CF. Highly host-adapted lineages harbored mutator genotypes displaying signatures of early genome degradation associated with recent host restriction. Using an advanced imaging technique (MiPACT-HCR [microbial identification after passive clarity technique]), we find population structure tracks with genome degradation, with the most host-adapted, genome-degraded P. aeruginosa (the mutators) residing in small, sparse aggregates. We propose that following initial adaptive evolution in larger populations under strong selection for aggregation, P. aeruginosa persists in small, fragmented populations that experience stronger effects of genetic drift. These conditions enrich for mutators and promote degenerative genome evolution. Our findings underscore the importance of infection-site biogeography to pathogen evolution.
- Published
- 2021
- Full Text
- View/download PDF
25. Escherichia coli O157:H7 (Enterohemorrhagic E. coli)
- Author
-
Roy Karl Werner, Jordan R. Werner, and Emily Pinter
- Published
- 2024
- Full Text
- View/download PDF
26. Contributors
- Author
-
Axel Adams, Clara Affun-Adegbulu, Rakan S. Al-Rasheed, Yasser A. Alaska, Abdulaziz D. Aldawas, Saleh Ali Alesa, George A. Alexander, Abdullah Ahmed Alhadhira, Fahad Saleha Alhajjaj, Hazem H. Alhazmi, Zainab Abdullah Alhussaini, Nawfal Aljerian, Majed Aljohani, Khaldoon H. AlKhaldi, Eyad Alkhattabi, Bryant Allen, Austin Almand, Moza M. Alnoaimi, Mohammad Alotaibi, Evan Avraham Alpert, Yasir A. Alrusayni, Mai Alshammari, Loui K. Alsulimani, Siraj Amanullah, Arian Anderson, David Arastehmanesh, Ali Ardalan, Killiam A. Argote-Araméndiz, Andrew W. Artenstein, Olivia E. Bailey, Russell Baker, Satchit Balsari, Gregory T. Banner, Fermin Barrueto M, Susan A. Bartels, Joshua J. Baugh, Frederic Berg, Vijai Bhola, William Binder, Michelangelo Bortolin, Vincent Bounes, Michael Bouton, Natasha Brown, Frederick M. Burkle, Jr, Lynn Barkley Burnett, Michele M. Burns, Nicholas V. Cagliuso, Sr, John Cahill, David W. Callaway, Duane C. Caneva, Srihari Cattamanchi, Alejandra Caycedo, Edward W. Cetaruk, Sneha Chacko, James C. Chang, Crystal Chiang, David T. Chiu, Gregory R. Ciottone, Jonathan Peter Ciottone, Melissa A. Ciottone, Robert A. Ciottone, Robert G. Ciottone, Vigen G. Ciottone, Alexander Clark, Jonathan Clark, Sean P. Conley, Joanne Cono, Arthur Cooper, Scott B. Cormier, Michael F. Court, Cord W. Cunningham, Fabrice Czarnecki, Supriya Davis, Timothy E. Davis, Gerard DeMers, Sharon Dilling, Ahmadreza Djalali, Timothy Donahoe, Joseph Donahue, Caleb Dresser, Jason Dylik, Benjamin Easter, Alexander Eastman, Laura Ebbeling, Chigozie Emetarom, Nir Eyal, Andrew J. Eyre, David J. Freeman, Franklin D. Friedman, Christie Fritz, Frederick Fung, Fiona E. Gallahue, Stephanie Chow Garbern, Mark E. Gebhart, William A. Gluckman, Craig Goolsby, Robert M. Gougelet, Fredrik Granholm, P. Gregg Greenough, Jennifer O. Grimes, Steve Grosse, Shamai A. Grossman, John T. Groves Jr, Tee L. Guidotti, George Guo, Sarah Haessler, Matthew M. Hall, John W. Hardin, Mason Harrell, Alexander Hart, MD, Melissa Harvey, Attila J. Hertelendy, PhD, Nishanth S. Hiremath, Jordan Hitchens, Christopher P. Holstege, Simon T. Horne, Steven Horng, Amer Hosin, Hans R. House, Pier Luigi Ingrassia, Fadi S. Issa, Irving 'Jake' Jacoby, Rajnish Jaiswal, Gregory Jay, J. Lee Jenkins, Josh W. Joseph, Shane Kappler, Mark E. Keim, Julie Kelman, Andrew R. Ketterer, Anas A. Khan, Ramu Kharel, Chetan U. Kharod, Thomas D. Kirsch, Anita Knopov, Max Kravitz, J. Austin Lee, Jay Lemery, Evan L. Leventhal, Jesse Loughlin, Stephanie Ludy, Brian J. Maguire, Selwyn E. Mahon, Paul M. Maniscalco, Philip Manners, Leonard Jay Marcus, Colton Margus, Taha M. Masri, Jeff Matthews, Sean D. McKay, Zeke J. McKinney, Robert K. McLellan, Eric J. McNulty, Faroukh Mehkri, Mandana Mehta, Rebecca A. Mendelsohn, Ofer Merin, Andrew Milsten, Dale M. Molé, Michael Sean Molloy, Ilaria Morelli, Jerry L. Mothershead, John Mulhern, Nicole F. Mullendore, Nicholas J. Musisca, Sonya Naganathan, Larry A. Nathanson, Erica L. Nelson, Lewis S. Nelson, Bradford A. Newbury, Kimberly Newbury, Ansley O’Neill, Robert Obernier, Jacopo M. Olagnero, Leonie Oostrom-Shah, Catherine Y. Ordun, Scott Parazynski, Andrew J. Park, Robert Partridge, Jeffrey S, James P. Phillips, Emily Pinter, David P. Polatty IV, Patrick Popieluszko, William Porcaro, Lawrence Proano, Peter B. Pruitt, Moiz Qureshi, Luca Ragazzoni, Murtaza Rashid, Paul Patrick Rega, Michael J. Reilly, Marc C. Restuccia, James J. Rifino, Paul M. Robben, Joy L. Rosenblatt, Kevin M. Ryan, Heather Rybasack-Smith, Richard James Salway, Daniel Samo, Leon D. Sanchez, Shawn M. Sanford, Ritu R. Sarin, Deesha Sarma, Jesse Schacht, Valarie Schwind, Geoffrey L. Shapiro, Joshua Sheehan, Brian Shreve, Grigor Simonyan, Devin M. Smith, E. Reed Smith, MD, Jack E. Smith, MA, Montray Smith, Peter B. Smulowitz, Angela M. Snyder, Joshua J. Solano, Bryan A. Stenson, Charles Stewart, M. Kathleen Stewart, Patrick Sullivan, Jared S. Supple, Derrick Tin, Jonathan Harris Valente, Kathryn M. Vear, P.R. Vidyalakshmi, Faith Vilas, Gary M. Vilke, Janna H. Villano, Amalia Voskanyan, C. James Watson, Nancy Weber, Scott G. Weiner, Brielle Weinstein, Eric S. Weinstein, Jordan R. Werner, Roy Karl Werner, MD, James D. Whitledge, Sage W. Wiener, Lauren Wiesner, Kenneth A. Williams, Robyn Wing, Richard E. Wolfe, Wendy Hin-Wing Wong, Robert Woolard, Prasit Wuthisuthimethawee, and Nadine A. Youssef
- Published
- 2024
- Full Text
- View/download PDF
27. Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling
- Author
-
Hao Wang, Wei Hou, Aldeb Perera, Carlee Bettler, Jordan R. Beach, Xianzhong Ding, Jun Li, Mitchell F. Denning, Asha Dhanarajan, Scott J. Cotler, Cara Joyce, Jun Yin, Fowsiyo Ahmed, Lewis R. Roberts, and Wei Qiu
- Subjects
EphA2 ,HCC ,AKT ,STAT3 ,JAK1 ,Biology (General) ,QH301-705.5 - Abstract
Summary: Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide. One major obstacle to treatment is a lack of effective molecular-targeted therapies. In this study, we find that EphA2 expression and signaling are enriched in human HCC and associated with poor prognosis. Loss of EphA2 suppresses the initiation and growth of HCC both in vitro and in vivo. Furthermore, CRISPR/CAS9-mediated EphA2 inhibition significantly delays tumor development in a genetically engineered murine model of HCC. Mechanistically, we discover that targeting EphA2 suppresses both AKT and JAK1/STAT3 signaling, two separate oncogenic pathways in HCC. We also identify a small molecule kinase inhibitor of EphA2 that suppresses tumor progression in a murine HCC model. Together, our results suggest EphA2 as a promising therapeutic target for HCC.
- Published
- 2021
- Full Text
- View/download PDF
28. The Top 50 Most-Cited Shoulder Arthroscopy Studies
- Author
-
M. Lane Moore, B.S., Jordan R. Pollock, B.S., Kade S. McQuivey, M.D., and Joshua S. Bingham, M.D.
- Subjects
Sports medicine ,RC1200-1245 - Abstract
Purpose: To determine the 50 most frequently cited studies in the orthopaedic shoulder arthroscopy literature and to conduct a bibliometric analysis of these studies. Methods: The Clarivate Analytics Web of Knowledge database was used to gather data and metrics using Boolean queries to capture all possible iterations of shoulder arthroscopy research. The search list was sorted so that articles were organized in descending order based on the number of citations and included or excluded based on relevance to shoulder arthroscopy. The information extracted for each article included author name, publication year, country of origin, journal name, article type, and the level of evidence. Results: For these 50 studies, the total number of citations was calculated to be 13,910, with an average of 278.2 citations per paper. The most-cited article was cited 1134 times, whereas the second- and third-most cited articles were cited 920 and 745 times, respectively. All 50 articles were published in English and came from 7 different orthopaedic journals. The United States was responsible for most of the included articles (31), followed by France (9) and Japan (3). Conclusions: The majority of the most-cited articles in shoulder arthroscopy are case series and descriptive studies originating from the United States. In addition, more than one half of the top 50 most-cited studies were published after 2004, which suggests that article age may be less important in the accumulation of citations for a rapidly growing field like shoulder arthroscopy. Clinical Relevance: The top 50 most-cited studies list will provide researchers, medical students, residents, and fellows with a foundational list of the most important and influential academic contributions to shoulder arthroscopy.
- Published
- 2021
- Full Text
- View/download PDF
29. Open data from the first and second observing runs of Advanced LIGO and Advanced Virgo
- Author
-
Rich Abbott, Thomas D. Abbott, Sheelu Abraham, Fausto Acernese, Kendall Ackley, Carl Adams, Rana X. Adhikari, Vaishali B. Adya, Christoph Affeldt, Michalis Agathos, Kazuhiro Agatsuma, Nancy Aggarwal, Odylio D. Aguiar, Amit Aich, Lorenzo Aiello, Anirban Ain, Ajith Parameswaran, Gabrielle Allen, Annalisa Allocca, Paul A. Altin, Alex Amato, Shreya Anand, Alena Ananyeva, Stuart B. Anderson, Warren G. Anderson, Svetoslava V. Angelova, Stefano Ansoldi, Sarah Antier, Stephen Appert, Koji Arai, Melody C. Araya, Joseph S. Areeda, Marc Arène, Nicolas Arnaud, Scott M. Aronson, Kg G. Arun, Stefano Ascenzi, Gregory Ashton, Stuart M. Aston, Pia Astone, Florian Aubin, Peter Aufmuth, Kellie AultONeal, Corey Austin, Valerie Avendano, Stanislav Babak, Philippe Bacon, Francesca Badaracco, Maria K.M. Bader, Sangwook Bae, Anne M. Baer, Jonathon Baird, Francesca Baldaccini, Giulio Ballardin, Stefan W. Ballmer, Anna-marie Bals, Alexander Balsamo, Gregory Baltus, Sharan Banagiri, Deepak Bankar, Rameshwar S. Bankar, Juan C. Barayoga, Claudio Barbieri, Barry C. Barish, David Barker, Kevin Barkett, Pablo Barneo, Fabrizio Barone, Bryan Barr, Lisa Barsotti, Matteo Barsuglia, Daniel Barta, Jeffrey Bartlett, Imre Bartos, Riccardo Bassiri, Andrea Basti, Mateusz Bawaj, Joseph C. Bayley, Marco Bazzan, Bence Bécsy, Michal Bejger, Imene Belahcene, Angus S. Bell, Deeksha Beniwal, Michael G. Benjamin, Joe D. Bentley, Fabio Bergamin, Beverly K. Berger, Gerald Bergmann, Sebastiano Bernuzzi, Christopher P.L. Berry, Diego Bersanetti, Alessandro Bertolini, Joseph Betzwieser, Rohan Bhandare, Ankit V. Bhandari, Jeffrey Bidler, Edward Biggs, Igor A. Bilenko, Garilynn Billingsley, Ross Birney, Ofek Birnholtz, Sebastien Biscans, Matteo Bischi, Sylvia Biscoveanu, Aparna Bisht, Guldauren Bissenbayeva, Massimiliano Bitossi, Marieanne A. Bizouard, Kent K. Blackburn, Jonathan Blackman, Carl D. Blair, David G. Blair, Ryan M. Blair, Fabrizio Bobba, Nina Bode, Michel Boer, Yannick Boetzel, Gilles Bogaert, Francois Bondu, Edgard Bonilla, Romain Bonnand, Phillip Booker, Boris A. Boom, Rolf Bork, Valerio Boschi, Sukanta Bose, Vladimir Bossilkov, Joel Bosveld, Yann Bouffanais, Antonella Bozzi, Carlo Bradaschia, Patrick R. Brady, Alyssa Bramley, Marica Branchesi, Jim E. Brau, Matteo Breschi, Tristan Briant, Joseph H. Briggs, Francesco Brighenti, Alain Brillet, Marc Brinkmann, Patrick Brockill, Aidan F. Brooks, Jonathan Brooks, Daniel D. Brown, Sharon Brunett, Giacomo Bruno, Robert Bruntz, Aaron Buikema, Tomasz Bulik, Henk J. Bulten, Alessandra Buonanno, Damir Buskulic, Robert L. Byer, Miriam Cabero, Laura Cadonati, Giampietro Cagnoli, Craig Cahillane, Juan Calderón Bustillo, Jack D. Callaghan, Thomas A. Callister, Enrico Calloni, Jordan B. Camp, Maurizio Canepa, Kipp C. Cannon, Huy-tuong Cao, Junwei Cao, Giovanni Carapella, Franco Carbognani, Santiago Caride, Matthew F. Carney, Gregorio Carullo, Julia Casanueva Diaz, Claudio Casentini, Javier Castañeda, Sarah Caudill, Marco Cavaglià, Fabien Cavalier, Roberto Cavalieri, Giancarlo Cella, Pablo Cerdá-Durán, Elisabetta Cesarini, Oualid Chaibi, Kabir Chakravarti, Chiwai Chan, Manleong Chan, Shiuh Chao, Philip Charlton, Eve A. Chase, Eric Chassande-Mottin, Deep Chatterjee, Mayank Chaturvedi, Hsin-yu Y. Chen, Xu Chen, Yanbei Chen, Hai-ping Cheng, Chi-kit K. Cheong, Hanyu Y. Chia, Francesco Chiadini, Roberto Chierici, Andrea Chincarini, Antonino Chiummo, Gihyuk Cho, Heesuk S. Cho, Min-a Cho, Nelson Christensen, Qi Chu, Sheon Chua, Ka-wai W. Chung, Shinkee Chung, Giacomo Ciani, Pawel Ciecielag, Marek Cieślar, Alexei A. Ciobanu, Riccardo Ciolfi, Francesco Cipriano, Alessio Cirone, Filiberto Clara, James A. Clark, Patrick Clearwater, Sebastien Clesse, Frederic Cleva, Eugenio Coccia, Pierre-francois Cohadon, David Cohen, Marta Colleoni, Christophe G. Collette, Christopher Collins, Monica Colpi, Marcio Constancio Jr., Livia Conti, Sam J. Cooper, Paul Corban, Thomas R. Corbitt, Isabel Cordero-Carrión, Silvia Corezzi, Kenneth R. Corley, Neil Cornish, David Corre, Alessandra Corsi, Stefano Cortese, Cesar A. Costa, Roberto Cotesta, Michael W. Coughlin, Scott B. Coughlin, Jeanpierre Coulon, Stefan T. Countryman, Peter Couvares, Pep B. Covas, David M. Coward, Matthew J. Cowart, Dennis C. Coyne, Robert Coyne, Jolien D. E. Creighton, Teviet D. Creighton, Jonathan Cripe, Michael Croquette, Sgwynne G. Crowder, Jean-rene Cudell, Torrey J. Cullen, Alan Cumming, Rebecca Cummings, Liam Cunningham, Elena Cuoco, Malgorzata Curylo, Tito Dal Canton, Gergely Dálya, Aykutlu Dana, Lara M. Daneshgaran-Bajastani, Beatrice D’Angelo, Stefan L. Danilishin, Sabrina D’Antonio, Karsten Danzmann, Christian Darsow-Fromm, Arnab Dasgupta, Laurence E. H. Datrier, Vincenzo Dattilo, Ishant Dave, Michel Davier, Gareth S. Davies, Derek Davis, Edward J. Daw, Dan DeBra, Malathi Deenadayalan, Jerome Degallaix, Martina De Laurentis, Samuel Deléglise, Matthew Delfavero, Nicola De Lillo, Walter Del Pozzo, Lindsay M. DeMarchi, Virginia D’Emilio, Nicholas Demos, Thomas Dent, Roberto De Pietri, Rosario De Rosa, Camilla De Rossi, Riccardo DeSalvo, Omar de Varona, Sanjeev Dhurandhar, Mario C. Díaz, Mauricio Diaz-Ortiz Jr., Tim Dietrich, Luciano Di Fiore, Chiara Di Fronzo, Cinzia Di Giorgio, Fabrizio Di Giovanni, Matteo Di Giovanni, Tristano Di Girolamo, Alberto Di Lieto, Binlei Ding, Sibilla Di Pace, Irene Di Palma, Francesco Di Renzo, Atul K. Divakarla, Artemiy Dmitriev, Zoheyr Doctor, Fred Donovan, Katherine L. Dooley, Suresh Doravari, Iain Dorrington, Thomas P. Downes, Marco Drago, Jenne C. Driggers, Zhihui Du, Jean-gregoire Ducoin, Peter Dupej, Ofelia Durante, Domenico D’Urso, Sheila E. Dwyer, Paul J. Easter, Graeme Eddolls, Bruce Edelman, Tega B. Edo, Oliver Edy, Anamaria Effler, Phil Ehrens, Johannes Eichholz, Stephen S. Eikenberry, Marc Eisenmann, Robert A. Eisenstein, Aldo Ejlli, Lucianolucianikerrico Errico, Reed C. Essick, Hector Estelles, Dimitri Estevez, Zachariah B. Etienne, Todd Etzel, Matthew Evans, Tom M. Evans, Rebecca E. Ewing, Viviana Fafone, Stephen Fairhurst, Xilong Fan, Stefania Farinon, Benjamin Farr, Will M. Farr, Edward J. Fauchon-Jones, Marc Favata, Maxime Fays, Mariana Fazio, Jon Feicht, Martin M. Fejer, Fangchen Feng, Edit Fenyvesi, Deborah L. Ferguson, Alvaro Fernandez-Galiana, Isidoro Ferrante, Elvis C. Ferreira, Tabata A. Ferreira, Francesco Fidecaro, Irene Fiori, Donatella Fiorucci, Maya Fishbach, Ryan P. Fisher, Rosalba Fittipaldi, Margot Fitz-Axen, Vincenzo Fiumara, Raffaele Flaminio, Erik Floden, Eric Flynn, Heather Fong, Antonio A. Font, Perry Forsyth, Jean-daniel Fournier, Sergio Frasca, Franco Frasconi, Zsolt Frei, Andreas Freise, Raymond Frey, Valentin Frey, Peter Fritschel, Valery V. Frolov, Gabriele Fronzè, Paul Fulda, Michael Fyffe, Hunter A. Gabbard, Bhooshan U. Gadre, Sebastian M. Gaebel, Jonathan R. Gair, Shanika Galaudage, Dhruva Ganapathy, Sharad G. Gaonkar, Cecilio García-Quirós, Fabio Garufi, Bubba Gateley, Sergio Gaudio, Gayathri Gayathri, Gianluca Gemme, Eric Genin, Alberto Gennai, Daniel George, Jogy George, Laszlo Gergely, Sudarshan Ghonge, Abhirup Ghosh, Archisman Ghosh, Shaon Ghosh, Bruno Giacomazzo, Joe A. Giaime, Dwayne D. Giardina, Des R. Gibson, Chalisa Gier, Kiranjyot Gill, Jane Glanzer, Jan Gniesmer, Patrick Godwin, Evan Goetz, Ryan Goetz, Niklas Gohlke, Boris Goncharov, Gabriela González, Gopakumar Gopakumar, Sarah E. Gossan, Matthieu Gosselin, Romain Gouaty, Benjamin Grace, Aniello Grado, Massimo Granata, Alastair Grant, Slawomir Gras, Philippe Grassia, Corey Gray, Rachel Gray, Giuseppe Greco, Anna C. Green, Rhys Green, Elizabeth M. Gretarsson, Hannah L. Griggs, G. Grignani, Andrea Grimaldi, Stefan J. Grimm, Hartmut Grote, Steffen Grunewald, Pierre Gruning, Gianluca M. Guidi, Andre R. Guimaraes, Gerard Guixé, Hitesh K. Gulati, Yuefan Guo, Anuradha Gupta, Anchal Gupta, Pawan Gupta, Eric K. Gustafson, Dick Gustafson, Leila Haegel, Odysse Halim, Evan D. Hall, Eleanor Z. Hamilton, Giles Hammond, Maria Haney, Manuela M. Hanke, Jonathan Hanks, Chad Hanna, Mark D. Hannam, Otto A. Hannuksela, Travis J. Hansen, Joe Hanson, Thomas Harder, Terra Hardwick, Haris Haris, Jan Harms, Gregg M. Harry, Ian W. Harry, Raine K. Hasskew, Carl-johan Haster, Karen Haughian, Fergus J. Hayes, James Healy, Antoine Heidmann, Matthew C. Heintze, Joscha Heinze, Henrich Heitmann, Frances Hellman, Patrice Hello, Gary Hemming, Martin Hendry, Siong S. Heng, Eric Hennes, Jan-simon Hennig, Michele Heurs, Stefan Hild, Tanja Hinderer, Sarah Y. Hoback, Sven Hochheim, Elyssa Hofgard, David Hofman, Aaron M. Holgado, Nathan A. Holland, Kathy Holt, Daniel E. Holz, Paul Hopkins, Christian Horst, James Hough, Eric J. Howell, Charlie G. Hoy, Yiwen Huang, Moritz T. Hübner, Eliu A. Huerta, Dominique Huet, Brennan Hughey, Victor Hui, Sascha Husa, Sabina H. Huttner, Rachael Huxford, Tien Huynh-Dinh, Bartosz Idzkowski, Alberto Iess, Henri Inchauspe, Craig Ingram, Giuseppe Intini, Jean M. Isac, Max Isi, Bala R. Iyer, Thibaut Jacqmin, Sameer J. Jadhav, Shreejit P. Jadhav, Alasdair L. James, Karan Jani, Nagaraj N. Janthalur, Piotr Jaranowski, Deep Jariwala, Rafel Jaume, Alex C. Jenkins, Jun Jiang, Grace R. Johns, Aaron W. Jones, Ian I. Jones, Jeff D. Jones, Philip Jones, Russell Jones, Reinier J. G. Jonker, Ju Ju, Jonas Junker, Chinmay V. Kalaghatgi, Vassiliki Kalogera, Brittany Kamai, Shivaraj Kandhasamy, Gungwon Kang, Jonah B. Kanner, Shasvath J. Kapadia, Sudarshan Karki, Rahul Kashyap, Marie Kasprzack, Wolfgang Kastaun, Stavros Katsanevas, Erik Katsavounidis, William Katzman, Steffen Kaufer, Keita Kawabe, Fabien Kéfélian, David Keitel, Azadeh Keivani, Ross Kennedy, Joey S. Key, Sudiksha Khadka, Farit Y. Khalili, Imran Khan, Sebastian Khan, Zaki A. Khan, Efim A. Khazanov, Nandita Khetan, Mohammad Khursheed, Nutsinee Kijbunchoo, Chunglee Kim, Grace J. Kim, Jeongcho C. Kim, Kyungmin Kim, Won Kim, Whansun S. Kim, Young-min Kim, Charles Kimball, Peter J. King, Maya Kinley-Hanlon, Robin Kirchhoff, Jeffrey S. Kissel, Lisa Kleybolte, Sergei Klimenko, Tyler D. Knowles, Philip Koch, Sina M. Koehlenbeck, Gideon Koekoek, Soumen Koley, Veronica Kondrashov, Antonios Kontos, Nico Koper, Mikhail Korobko, William Z. Korth, Manoj Kovalam, Dan B. Kozak, Volker Kringel, Nv V. Krishnendu, Andrzej Królak, Natalie Krupinski, Gerrit Kuehn, Anil Kumar, Prayush Kumar, Rahul Kumar, Rakesh Kumar, Sumit Kumar, Ling-chi Kuo, Adam Kutynia, Benjamin D. Lackey, Danny Laghi, Emile Lalande, Lam L. Lam, Astrid Lamberts, Michael Landry, Benjamin B. Lane, Ryan N. Lang, Jacob Lange, Brian Lantz, Robert K. Lanza, Iuri La Rosa, Angelique Lartaux-Vollard, Paul D. Lasky, Michael Laxen, Albert Lazzarini, Claudia Lazzaro, Paola Leaci, Sean Leavey, Yannick K. Lecoeuche, Chang-hwan H. Lee, Hyung-mok M. Lee, Hyungwon W. Lee, Joongoo Lee, Kyung-ha Lee, Johannes Lehmann, Nicolas Leroy, Nicolas Letendre, Yuri Levin, Alvin K. Y. Li, Jin Li, Kaye li, Tjonnie G. F. Li, Xiang Li, Frank Linde, Seth D. Linker, Jethro N. Linley, Tyson B. Littenberg, Liu Liu, Xiaoshu Liu, Miquel Llorens-Monteagudo, Ka-lok Lo, Alexandra Lockwood, Lionel T. London, Alessandro Longo, Matteo Lorenzini, Vincent Loriette, Marc Lormand, Giovanni Losurdo, James D. Lough, Carlos O. Lousto, Geoffrey Lovelace, Harald Lück, Diana Lumaca, Andrew P. Lundgren, Ma Yiqiu, Ronaldas Macas, Sean Macfoy, Myron MacInnis, Duncan M. Macleod, Ian O. MacMillan, Adrian Macquet, Ignacio Magaña Hernandez, Fabian Magaña-Sandoval, Ryan M. Magee, Ettore Majorana, Ivan Maksimovic, Asmita Malik, Catherine Man, Vuk Mandic, Valentina Mangano, Georgia L. Mansell, Michael Manske, Maddalena Mantovani, Michela Mapelli, Fabio Marchesoni, Frederique Marion, Szabolcs Márka, Zsuzsanna Márka, Charalampos Markakis, Ashot S. Markosyan, Aaron Markowitz, Ed Maros, Antonio Marquina, Sylvain Marsat, Filippo Martelli, Ian W. Martin, Rodica M. Martin, Valerie Martinez, Denis V. Martynov, Hossein Masalehdan, Ken Mason, Elena Massera, Alain Masserot, Thomas J. Massinger, Mariela Masso-Reid, Simone Mastrogiovanni, Andrew Matas, Fabrice Matichard, Nergis Mavalvala, Emily Maynard, Joshua J. McCann, Richard McCarthy, David E. McClelland, Scott McCormick, Lee McCuller, Stephen C. McGuire, Connor McIsaac, Jessica McIver, David J. McManus, Terry McRae, Sean T. McWilliams, Duncan Meacher, Grant D. Meadors, Moritz Mehmet, Ajit K. Mehta, Elena Mejuto Villa, Andrew Melatos, Gregory Mendell, Adam A. Mercer, Lorenzo Mereni, Kara Merfeld, Edmond L. Merilh, Jonathan D. Merritt, Mourad Merzougui, Syd Meshkov, Chris Messenger, Cody Messick, Remi Metzdorff, Patrick M. Meyers, Fabian Meylahn, Ashish Mhaske, Andrea Miani, Haixing Miao, Ioannis Michaloliakos, Christophe Michel, Hannah Middleton, Leopoldo Milano, Andrewlawrence L. Miller, Meg Millhouse, Joseph C. Mills, Edoardo Milotti, Michael C. Milovich-Goff, Olivier Minazzoli, Yuri Minenkov, Alec Mishkin, Chandra Mishra, Timesh Mistry, Sanjit Mitra, Valery P. Mitrofanov, Guenakh Mitselmakher, Richard Mittleman, Geoffrey Mo, Kentaro Mogushi, Satyanarayan R. P. Mohapatra, Siddharth R. Mohite, Manel Molina-Ruiz, Marina Mondin, Matteo Montani, Christopher J. Moore, Dan Moraru, Filip Morawski, Gerardo Moreno, Soichiro Morisaki, Benoit Mours, Conor M. Mow-Lowry, Simone Mozzon, Federico Muciaccia, Arunava Mukherjee, Debnandini Mukherjee, Soma Mukherjee, Subroto Mukherjee, Nikhil Mukund, Adam Mullavey, Jesper Munch, Erik A. Muñiz, Peter G. Murray, Alessandro Nagar, Ilaria Nardecchia, Luca Naticchioni, Rajesh K. Nayak, Benjamin F. Neil, Joshua Neilson, Gijs Nelemans, Timothy J. N. Nelson, Marina Nery, Ansel Neunzert, Kwan-yeung Y. Ng, Sebastian Ng, Catherine Nguyen, Philippe Nguyen, David Nichols, Shania A. Nichols, Samaya Nissanke, Flavio Nocera, Minkyun Noh, Chris North, Devon Nothard, Laura K. Nuttall, Jason Oberling, Brendan D. O’Brien, Gor Oganesyan, Greg H. Ogin, John J. Oh, Sanghoon H. Oh, Frank Ohme, Hiroaki Ohta, Marcos A. Okada, Miquel Oliver, Christian Olivetto, Patrick Oppermann, Richard Oram, Brian O’Reilly, Rich G. Ormiston, Luis F. Ortega, Richard O’Shaughnessy, Serguei Ossokine, Charles Osthelder, David J. Ottaway, Harry Overmier, Ben J. Owen, Alexander E. Pace, Giulia Pagano, Michael A. Page, Giulia Pagliaroli, Archana Pai, Siddhesh A. Pai, Jordan R. Palamos, Oleg Palashov, Cristiano Palomba, Howard Pan, Pratap K. Panda, Tsun-ho Pang, Chris Pankow, Francesco Pannarale, Brijesh C. Pant, Federico Paoletti, Andrea Paoli, Abhishek Parida, William Parker, Daniela Pascucci, Antonio Pasqualetti, Roberto Passaquieti, Diego Passuello, Barbara Patricelli, Ethan Payne, Brynley L. Pearlstone, Thida C. Pechsiri, Ari J. Pedersen, Mike Pedraza, Arnaud Pele, Steven Penn, Albino Perego, Carlos J. Perez, Perigois Périgois, Antonio Perreca, Stephane Perriès, Jan Petermann, Harald P. Pfeiffer, Margot Phelps, Khun S. Phukon, Ornella J. Piccinni, Mikhael Pichot, Marco Piendibene, Francesco Piergiovanni, Vincenzo Pierro, Gabriel Pillant, Laurent Pinard, Innocenzo M. Pinto, Krzysztof Piotrzkowski, Marc Pirello, Matthew Pitkin, Wolfango Plastino, Rosa Poggiani, Yat-tung T. Pong, Sarah Ponrathnam, Pasquale Popolizio, Ed K. Porter, Jade Powell, Atul K. Prajapati, Kiran Prasai, Raghurama Prasanna, Geraint Pratten, Tanner Prestegard, Maria Principe, Giovanni A. Prodi, Leonid Prokhorov, Michele Punturo, Paola Puppo, Michael Pürrer, Hong Qi, Volker Quetschke, Pedro J. Quinonez, Fred J. Raab, Geert Raaijmakers, Hugh Radkins, Nicholas Radulesco, Peter Raffai, Hanna Rafferty, Sendhil Raja, Rajan Rajan, Binod Rajbhandari, Malik Rakhmanov, Karla E. Ramirez, Antoni Ramos-Buades, Javed Rana, Kaushik Rao, Piero Rapagnani, Vivien Raymond, Massimiliano Razzano, Jocelyn Read, Tania Regimbau, Luca Rei, Stuart Reid, David H. Reitze, Piero Rettegno, Fulvio Ricci, Colter J. Richardson, Jonathan W. Richardson, Paul M. Ricker, Gunnar Riemenschneider, Keith Riles, Monica Rizzo, Norna A. Robertson, Florent Robinet, Alessio Rocchi, Ramon D. Rodriguez-Soto, Loic Rolland, Jameson G. Rollins, Vincent J. Roma, Marco Romanelli, Rocco Romano, Chandra L. Romel, Isobel M. Romero-Shaw, Janeen H. Romie, Caitlin A. Rose, Dakota Rose, Kyle Rose, Dorota Rosińska, Shawn G. Rosofsky, Michael P. Ross, Sheila Rowan, Samuel J. Rowlinson, Palash K. Roy, Santosh Roy, Soumen Roy, Paolo Ruggi, Guntis Rutins, Kyle Ryan, Surabhi Sachdev, Travis Sadecki, Mairi Sakellariadou, Om S. Salafia, Livio Salconi, Muhammed Saleem, Anuradha Samajdar, Eduardo J. Sanchez, Luis E. Sanchez, Nicolas Sanchis-Gual, Jaclyn R. Sanders, Kevin A. Santiago, Edison Santos, Nikhil Sarin, Benoit Sassolas, B S. Sathyaprakash, Orion Sauter, Richard L. Savage, Vaibhav Savant, Disha Sawant, Sihem Sayah, Dean Schaetzl, Paul Schale, Mark Scheel, Jacob Scheuer, Patricia Schmidt, Roman Schnabel, Robert M. S. Schofield, Axel Schönbeck, Emil Schreiber, Bernd W. Schulte, Bernard F. Schutz, Otto Schwarm, Eyal Schwartz, Jamie Scott, Susan M. Scott, Ed Seidel, Danny Sellers, Anand S. Sengupta, Noah Sennett, Daniel Sentenac, Valeria Sequino, Alexander Sergeev, Yoshinta Setyawati, Daniel A. Shaddock, Thomas Shaffer, Selim S. Shahriar, A. Sharma, Priyanka Sharma, Peter Shawhan, Hongyu Shen, Minori Shikauchi, Rosalie Shink, David H. Shoemaker, Deirdre M. Shoemaker, Keerti Shukla, Shyamsundar ShyamSundar, Karelle Siellez, Magdalena Sieniawska, Daniel Sigg, Leo P. Singer, Divya Singh, Neha Singh, Ayatri Singha, Akshat Singhal, Alicia M. Sintes, Valeria Sipala, Vasileios Skliris, Bram J. J. Slagmolen, Teresa J. Slaven-Blair, Jiri Smetana, Joshua R. Smith, Rory J. E. Smith, Surendranadh Somala, Edwin J. Son, Siddharth Soni, Borja Sorazu, Viola Sordini, Fiodor Sorrentino, Tarun Souradeep, Eric Sowell, Andrew P. Spencer, Mario Spera, Amit K. Srivastava, Varun Srivastava, Kai Staats, Cosmin Stachie, Mark Standke, Daniele A. Steer, Michael Steinke, Jessica Steinlechner, Sebastian Steinlechner, Daniel Steinmeyer, Dane Stocks, David J. Stops, Madeline Stover, Ken A. Strain, Giulia Stratta, Amber Strunk, Riccardo Sturani, Amber L. Stuver, Sudhagar Sudhagar, Vivishek Sudhir, Tiffany Z. Summerscales, Ling Sun, Sunil Sunil, Ankan Sur, Jishnu Suresh, Patrick J. Sutton, Bas L. Swinkels, Marek J. Szczepańczyk, Matteo Tacca, Simon C. Tait, Colm Talbot, Andres J. Tanasijczuk, David B. Tanner, Duo Tao, Marton Tápai, Amauri Tapia, Enzo N. Tapia San Martin, Jay D. Tasson, Robert Taylor, Rodrigo Tenorio, Lukas Terkowski, Manasadevi P. Thirugnanasambandam, Michael Thomas, Patrick Thomas, Jonathan E. Thompson, Sivananda R. Thondapu, Keith A. Thorne, Eric Thrane, Calley L. Tinsman, Saravanan R. Saravanan, Shubhanshu Tiwari, Srishti Tiwari, Vaibhav Tiwari, Karl Toland, Mauro Tonelli, Zeno Tornasi, Alejandro Torres-Forné, Calum I. Torrie, Iara Tosta e Melo, Daniel Töyrä, Emily A. Trail, Flavio Travasso, Gary Traylor, Maria C. Tringali, Aashish Tripathee, Agata Trovato, Randy J. Trudeau, Ka-wa W. Tsang, Maggie Tse, Rhondale Tso, Leo Tsukada, Daichi Tsuna, Takuya Tsutsui, Margherita Turconi, Amit S. Ubhi, Koh Ueno, Dennis Ugolini, Cs S. Unnikrishnan, Alexander L. Urban, Samantha A. Usman, Andrei C. Utina, Henning Vahlbruch, Gabriele Vajente, Guillermo Valdes, Michele Valentini, M. Vallisneri, Niels van Bakel, Martin van Beuzekom, Jo F. J. van den Brand, Chris Van Den Broeck, Daniel C. Vander-Hyde, Laura van der Schaaf, Joris V. Van Heijningen, Marielle A. van Veggel, Marco Vardaro, Vijay Varma, Steve Vass, Matyas Vasúth, Alberto Vecchio, Gabriele Vedovato, John Veitch, Peter J. Veitch, Krishna Venkateswara, Gautam Venugopalan, Didier Verkindt, Doga Veske, Flavio Vetrano, Andrea Viceré, Aaron D. Viets, Serena Vinciguerra, David J. Vine, Jeanyves Vinet, Salvatore Vitale, Francisco Hernandez Vivanco, Thomas Vo, Helios Vocca, Cheryl Vorvick, Sergey P. Vyatchanin, Andrew R. Wade, Leslie E. Wade, Madeline Wade, Rob Walet, Marissa Walker, Gavin S. Wallace, Larry Wallace, Sinead Walsh, Jonathan Z. Wang, Sibo Wang, Wenhui H. Wang, Yifan F. Wang, Robert L. Ward, Zane A. Warden, Jim Warner, Michal Was, Jennifer Watchi, Betsy Weaver, Li-wei Wei, Michael Weinert, Alan J. Weinstein, Rainer Weiss, Felix Wellmann, Linqing Wen, Peter Weßels, Jonathan W. Westhouse, Karl Wette, John T. Whelan, Bernard F. Whiting, Chris Whittle, Dennis M. Wilken, Daniel Williams, Roy D. Williams, Andrew R. Williamson, Joshua L. Willis, Benno Willke, Walter Winkler, Christopher C. Wipf, Holger Wittel, Graham Woan, Janis Woehler, Jared K. Wofford, Chun-fung Wong, Jennifer L. Wright, David S. Wu, Daniel M. Wysocki, Liting Xiao, Hiro Yamamoto, Le Yang, Yang Yang, Ziyan Yang, Min-jet J. Yap, Maher Yazback, David W. Yeeles, Hang Yu, Haocun Yu, Shingheirobin Yuen, Adam K. Zadrożny, Adam Zadrożny, Michele Zanolin, Tatiana Zelenova, Jean-pierre Zendri, Michael Zevin, Jue Zhang, Liyuan Zhang, Teng Zhang, Chunnong Zhao, Guoying Zhao, Minchuan Zhou, Zifan Zhou, Xingjiang J. Zhu, Aaron B. Zimmerman, Michael E. Zucker, and John Zweizig
- Subjects
GWOSC ,Scientific databases ,Data representation and management ,Gravitational Waves ,Computer software ,QA76.75-76.765 - Abstract
Advanced LIGO and Advanced Virgo are monitoring the sky and collecting gravitational-wave strain data with sufficient sensitivity to detect signals routinely. In this paper we describe the data recorded by these instruments during their first and second observing runs. The main data products are gravitational-wave strain time series sampled at 16384 Hz. The datasets that include this strain measurement can be freely accessed through the Gravitational Wave Open Science Center at http://gw-openscience.org, together with data-quality information essential for the analysis of LIGO and Virgo data, documentation, tutorials, and supporting software.
- Published
- 2021
- Full Text
- View/download PDF
30. List of contributors
- Author
-
Adams, Jennifer, primary, Agarwal, Sanjiv, additional, Ahmad, Imtiaz, additional, Akolkar, Sameer K., additional, Almada, Anthony L., additional, Al-Mondhiry, Rend, additional, Aruoma, Okezie I., additional, Bagchi, Debasis, additional, Bahorun, Theeshan, additional, Bailey, Jordan R., additional, Bhupathiraju, Kiran, additional, Bond, Katie, additional, Burdock, George A., additional, Carabin, Ioana G., additional, Cavaliere, Alessia, additional, Chahar, Digambar, additional, Chakraborty, Pradip, additional, Chen, Jayson, additional, Chinlund, Gregory J., additional, Chong, Leighton K., additional, Coppens, Patrick, additional, Crawford, Willette M., additional, Das, Amitava, additional, Datla, Praneel, additional, Del Bo’, Cristian, additional, Downs, Bernard W., additional, Duffy, Meggan F., additional, Duttaroy, Asim K., additional, Farrell, Matthew, additional, Frey, Thomas, additional, Ghosh, Dilip, additional, Ghosh, Nandini, additional, Golakoti, Trimurtulu, additional, Gowda, Raghavendra, additional, Griffiths, James C., additional, Gulati, Neelam, additional, Gulati, Om P., additional, Harrison, John R., additional, Harvey, Michael, additional, Hoadley, James E., additional, Hordvik, Stein, additional, Hu, Chun, additional, Ikeda, Hideko, additional, Jackson, Michelle C., additional, Jarouliya, Urmila, additional, Jennings, Sam, additional, Jeong, Sewon, additional, Johnson, Danielle K., additional, Keservani, Raj K., additional, Kim, Ji Yeon, additional, Kim, Seong Ju, additional, Kochetkova, Alla A., additional, Krishnaraju, Alluri V., additional, Lattimore, Lisa Glymph, additional, Lau, Teck-Chai, additional, Lewis, Claudia A., additional, Martini, Daniela, additional, McGee, Nikita, additional, McMullin, Colleen, additional, Mendes, Odete, additional, Morar, Sandra, additional, Moriyama, Hiroyoshi, additional, Murray, Chelsea M., additional, Neergheen-Bhujun, Vidushi S., additional, Nguyen, Haiuyen, additional, Ohama, Hirobumi, additional, Ottaway, Peter Berry, additional, Pinder, Tobey-Ann, additional, Powers, Jon-Paul, additional, Price, Rabbi Gavriel, additional, Radosevich, Jennifer, additional, Rawson, Nancy E., additional, Regenstein, Joe M., additional, Retik, Lewis, additional, Sen, Chandan K., additional, Sengupta, Krishanu, additional, Shao, Andrew, additional, Sharma, Anil K., additional, Sharp, Jeffrey S., additional, Shenkar, Julia, additional, Sheveleva, Svetlana A., additional, Shimizu, Makoto, additional, Smirnova, Elena A., additional, Sukhanov, Boris P., additional, Swaroop, Anand, additional, Tańska, Izabela, additional, Travis, John, additional, Tutelyan, Victor A., additional, Udell, Lawrence J., additional, White, Jessica, additional, and Zawistowski, Jerzy, additional
- Published
- 2019
- Full Text
- View/download PDF
31. Understanding medical foods under FDA regulations
- Author
-
Lewis, Claudia A., primary, Jackson, Michelle C., additional, and Bailey, Jordan R., additional
- Published
- 2019
- Full Text
- View/download PDF
32. Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis
- Author
-
Ross Dobie, John R. Wilson-Kanamori, Beth E.P. Henderson, James R. Smith, Kylie P. Matchett, Jordan R. Portman, Karolina Wallenborg, Simone Picelli, Anna Zagorska, Swetha V. Pendem, Thomas E. Hudson, Minnie M. Wu, Grant R. Budas, David G. Breckenridge, Ewen M. Harrison, Damian J. Mole, Stephen J. Wigmore, Prakash Ramachandran, Chris P. Ponting, Sarah A. Teichmann, John C. Marioni, and Neil C. Henderson
- Subjects
Biology (General) ,QH301-705.5 - Abstract
Summary: Iterative liver injury results in progressive fibrosis disrupting hepatic architecture, regeneration potential, and liver function. Hepatic stellate cells (HSCs) are a major source of pathological matrix during fibrosis and are thought to be a functionally homogeneous population. Here, we use single-cell RNA sequencing to deconvolve the hepatic mesenchyme in healthy and fibrotic mouse liver, revealing spatial zonation of HSCs across the hepatic lobule. Furthermore, we show that HSCs partition into topographically diametric lobule regions, designated portal vein-associated HSCs (PaHSCs) and central vein-associated HSCs (CaHSCs). Importantly we uncover functional zonation, identifying CaHSCs as the dominant pathogenic collagen-producing cells in a mouse model of centrilobular fibrosis. Finally, we identify LPAR1 as a therapeutic target on collagen-producing CaHSCs, demonstrating that blockade of LPAR1 inhibits liver fibrosis in a rodent NASH model. Taken together, our work illustrates the power of single-cell transcriptomics to resolve the key collagen-producing cells driving liver fibrosis with high precision. : Dobie et al. use scRNA-seq to reveal spatial and functional zonation of hepatic stellate cells (HSCs) across the hepatic lobule, identifying central vein-associated HSCs as the dominant pathogenic collagen-producing cells during centrilobular injury-induced fibrosis. This illustrates the power of scRNA-seq to resolve the key collagen-producing cells driving liver fibrosis. Keywords: liver fibrosis, mesenchyme, hepatic stellate cells, single-cell RNA sequencing, zonation
- Published
- 2019
- Full Text
- View/download PDF
33. How will climatic warming affect insect pollinators?
- Author
-
Meredith G. Johnson, Jordan R. Glass, Michael E. Dillon, and Jon F. Harrison
- Published
- 2023
- Full Text
- View/download PDF
34. Increasing severity of anemia is associated with poorer 30-day outcomes for total shoulder arthroplasty
- Author
-
Jordan R. Pollock, John M. Tokish, Jeffrey D. Hassebrock, Karan A. Patel, M. Lane Moore, Justin L. Makovicka, and Matthew K. Doan
- Subjects
medicine.medical_specialty ,Shoulder ,Multivariate analysis ,Anemia ,medicine.medical_treatment ,Osteoarthritis ,Outcomes ,Diseases of the musculoskeletal system ,Hematocrit ,Logistic regression ,Arthroplasty ,Internal medicine ,hemic and lymphatic diseases ,Medicine ,Orthopedics and Sports Medicine ,Major complication ,Orthopedic surgery ,medicine.diagnostic_test ,business.industry ,Postoperative complication ,medicine.disease ,RC925-935 ,Degenerative disease ,Surgery ,business ,RD701-811 - Abstract
Background: Total shoulder arthroplasty (TSA) has increased in utilization over the past several decades. Anemia is a common preoperative condition among patients undergoing TSA and has been associated with poorer outcomes in other surgical procedures. To the best of our knowledge, no study has analyzed the association between anemia severity and TSA outcomes. Therefore, the purpose of this study is to determine the effects that increasing severity of anemia may have on the postoperative outcomes in patients receiving primary TSA. Methods: A retrospective analysis was performed using the American College of Surgeons National Surgery Quality Improvement Project database from the years 2015 to 2018. Current Procedure Terminology code 23472 was used to identify all primary TSA procedures recorded during this time frame. Patients with greater than 38% preoperative hematocrit (HCT) were classified as having normal HCT levels. Patients with HCT values between 33% and 38% were classified as having mild anemia. All patients with less than 33% HCT were classified as having moderate/severe anemia. Patient demographic information, preoperative risk factors, and postoperative outcomes were compared among the 3 cohorts. A multivariate logistic regression including demographic factors and comorbidities was performed to determine whether increasing severity of anemia is independently associated with poorer postoperative outcomes. Results: Of the 15,185 patients included in this study, 11,404 had normal HCT levels, 2962 patients were mildly anemic, and 819 patients had moderate to severe anemia. With increasing severity of anemia, there was an increased average hospital length of stay (1.6 vs. 2.1 vs. 3.0 days, P
- Published
- 2021
35. N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial
- Author
-
Sarris, J, Byrne, G, Castle, D, Bousman, C, Oliver, G, Cribb, L, Blair-West, S, Brakoulias, V, Camfield, D, Ee, C, Chamoli, S, Boschen, M, Dean, Olivia, Dowling, N, Menon, R, Murphy, J, Metri, NJ, Nguyen, TP, Wong, A, Jordan, R, Karamacoska, D, Rossell, SL, Berk, Michael, Ng, CH, Sarris, J, Byrne, G, Castle, D, Bousman, C, Oliver, G, Cribb, L, Blair-West, S, Brakoulias, V, Camfield, D, Ee, C, Chamoli, S, Boschen, M, Dean, Olivia, Dowling, N, Menon, R, Murphy, J, Metri, NJ, Nguyen, TP, Wong, A, Jordan, R, Karamacoska, D, Rossell, SL, Berk, Michael, and Ng, CH
- Published
- 2022
36. Depletion of Beclin-1 due to proteolytic cleavage by caspases in the Alzheimer's disease brain
- Author
-
Troy T. Rohn, Ellen Wirawan, Raquel J. Brown, Jordan R. Harris, Eliezer Masliah, and Peter Vandenabeele
- Subjects
Beclin-1 ,Alzheimer's disease ,Astrocytes ,Caspase ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
The Beclin-1 protein is essential for the initiation of autophagy, and recent studies suggest this function may be compromised in Alzheimer's disease (AD). In addition, in vitro studies have supported a loss of function of Beclin-1 due to proteolytic modification by caspases. In the present study, we examined whether caspase-cleavage of Beclin-1 occurs in the AD brain by designing a site-directed caspase-cleavage antibody based upon a known cleavage site within the protein at position D149. We confirmed that Beclin-1 is an excellent substrate for caspase-3 and demonstrates cleavage led to the formation of a 35-kDa C-terminal fragment labeled by our novel antibody following Western blot analysis. Application of this antibody termed Beclin-1 caspase-cleavage product antibody or BeclinCCP in frontal cortex tissue sections revealed strong immunolabeling within astrocytes that localized with plaque regions and along blood vessels in all AD cases examined. In addition, weaker, more variable BeclinCCP labeling was also observed within neurofibrillary tangles that colocalized with the early tau conformational marker, MC-1 as well as the late tangle marker, PHF-1. Collectively, these data support a depletion of Beclin-1 in AD following caspase-cleavage. This article is part of a Special Issue entitled “Autophagy and protein degradation in neurological diseases.”
- Published
- 2011
- Full Text
- View/download PDF
37. Top-100 Most-Cited Sports-Related Concussion Articles Focus on Symptomatology, Epidemiology, and Demographics
- Author
-
Karan A. Patel, Anikar Chhabra, Jordan R. Pollock, Jeffrey D. Hassebrock, M. Lane Moore, and Kade S. McQuivey
- Subjects
medicine.medical_specialty ,business.industry ,Rehabilitation ,Public Health, Environmental and Occupational Health ,Physical Therapy, Sports Therapy and Rehabilitation ,Evidence-based medicine ,medicine.disease ,Country of origin ,Analytics ,Family medicine ,Epidemiology ,Concussion ,Sports medicine ,medicine ,Relevance (law) ,Original Article ,Orthopedics and Sports Medicine ,Psychology ,Citation ,business ,RC1200-1245 ,Cohort study - Abstract
Purpose To analyze the top-100 cited articles on sports-related concussions together with a bibliometric analysis to determine citations by year, level of evidence, study design, and several other factors related to the top referenced articles in sports concussions. Methods The Clarivate Analytics Web of Knowledge database was used to gather data using Boolean queries to capture all possible iterations of sports-related concussion research. Articles were organized in descending order based on the number of citations and included or excluded based on relevance to concussion. Collected information included author name, publication year, country of origin, journal name, article type, study focus, and the level of evidence. Results The top-100 articles were cited 31,197 times with an average of 312.0 citations per publication. More than one half were published in 2006 or later (52). Cohort studies and descriptive articles were the most prevalent study types (22 each). Studies with Level V evidence were the most common (33). The most common areas of study were symptomatology (short term, long term) with 17 articles, followed by epidemiology/demographics with 16 articles. The least common area of study was concussion prevention (2 articles), followed by management/treatment, diagnostics (labs, imaging) with 4 articles each. Conclusions We identified the most influential studies in sports-related concussion based on number of citations and citation density. A majority of these articles were published in the United States after 2006 and are most commonly cohort studies (Level IV evidence) and descriptive articles (Level V evidence). Current research focuses most heavily on the symptomatology and epidemiology/demographics of sports concussion. Clinical Relevance This study serves to identify the most influential articles in sports-related concussion and identify research topics with general deficiencies within the field of sports-related concussion research.
- Published
- 2021
38. Women and Men National Collegiate Athletic Association Ice Hockey Players Were Similarly Likely to Suffer Lumbar Spine Injuries
- Author
-
Joseph C. Brinkman, Anna S. Jenkins, Jeffrey D. Hassebrock, Anikar Chhabra, Sailesh V. Tummala, Justin L. Makovicka, Jordan R. Pollock, and Merritt C. Kropelnicki
- Subjects
medicine.medical_specialty ,business.industry ,injury ,lumbar spine ,Rehabilitation ,Public Health, Environmental and Occupational Health ,NCAA ,Physical Therapy, Sports Therapy and Rehabilitation ,Ice hockey ,ice hockey ,Sports medicine ,Physical therapy ,medicine ,Orthopedics and Sports Medicine ,Lumbar spine ,Original Article ,Association (psychology) ,business ,RC1200-1245 - Abstract
Purpose: To describe and compare the epidemiology of lumbar spine injuries (LSIs) in women’s and men’s ice hockey during the 2009-2010 to 2013-2014 academic years and to investigate sex-specific differences, using data from the National Collegiate Athletic Association (NCAA) Injury Surveillance Program (ISP) database. Methods: The incidence and characteristics of LSIs were identified utilizing the NCAA ISP. Rates of injury were calculated as number of injuries divided by total number of athlete exposures (AEs). AEs were defined as any student participation in one NCAA-sanctioned practice or competition. Incidence rate ratios (IRRs) were calculated to compare rates of injury between season, event type, mechanism, injury recurrence, and time lost from sport, and injury proportion ratios (IPRs) were calculated to examine the differences in injury rates between men and women. Results: There were a total of 165 LSIs from an average of 10 and 19 women’s and men’s teams, respectively, calculated to 1,254 LSIs nationally. Women were 2.48 times more likely to suffer a noncontact injury than men (95% CI: 1.33-4.61), whereas men were more likely than women to suffer contact LSIs (IPR: .51 [95% CI: .28-.92]). In Divisions II and III, women were 6.64 (95% CI: 4.14-10.64) and 1.28 (95% CI: 1.12-1.46) times more likely to suffer LSIs than men, respectively. Conclusions: Women and men were similarly likely to suffer an LSI, but sex-specific differences existed in a mechanism of injury and likelihood of injury within NCAA Divisions.
- Published
- 2021
39. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
- Author
-
Jordan R. Barrett, Adam Finn, Julie Furze, Rajeka Lazarus, Robert Aley, Emma Plested, Nicholas Byard, Alison M. Lawrie, Jack E. Saunders, Catherine C. Smith, Katie J. Ewer, Hannah Davies, Amber Thompson, Jonathan Kwok, Danielle Woods, Luke Blackwell, M N Ramasamy, Wanwisa Dejnirattisai, Hannah Roberts, Conor Whelan, Elizabeth F Jones, Vincenzo Libri, Mutjaba Ghulam Farooq, D Jenkin, D Bellamy, Mimi M. Hou, Alexander D. Douglas, Sarah Kelly, Adrian V. S. Hill, Sarah C. Gilbert, Christine S. Rollier, Megan Baker, Matthew Rajan, Liaquat Khan, E. Thomson, Amy Boyd, Rebecca Beckley, Phillip Baker, Stanislava Koleva, Louise Bates, Simon Kerridge, David J. Smith, Emma Francis, Christina Dold, Brian Angus, Christopher J A Duncan, Raquel Lopez Ramon, Andrew Smith, Alice Bridges-Webb, Thomas C. Hart, R Song, O Mazur, L Silva-Reyes, Claudio Di Maso, Rabiullah Noristani, Patrick J. Lillie, Marco Polo Peralta Alvarez, Matthew D. Snape, Wendy E.M. Crocker, Patrick Kinch, Charles H. Brown, Jasmin Kinch, Angela M. Minassian, M Bittaye, Jilly Muller, Emma V. Sheehan, J Aboagye, Anna L. Goodman, Iain Turnbull, Julia L. Marshall, Kirsten Beadon, Tanya Dinesh, R Makinson, Hannah Sharpe, Indra Rudiansyah, Jade Keen, Yama F Mujadidi, Laura L. Walker, Marta Ulaszewska, Baktash Khozoee, Jonathan Bell, Cameron Bissett, Robert Shaw, E Howe, Amy Beveridge, Cheryl Turner, Holly Smith, Karly Tang, Federica Cappuccini, Syed Adlou, Juthathip Mongkolsapaya, Estée M. Török, Spyridoula Marinou, Joanne McEwan, Rachel Cooper, David P. J. Turner, Merin Thomas, Tonia M. Thomas, Nicola Greenwood, Gavin R. Screaton, Sally Felle, S Bibi, Carla Ferreira Da Silva, P M Folegatti, Jolynne Mokaya, Sophia Hawkins, Elizabeth A. Clutterbuck, Ian D. Poulton, Andy Yao, Reece Mabbett, Christopher A Green, Emma Marlow, Mark Toshner, Heather Bletchly, Alexandra J. Spencer, Rebecca K. Sutherland, Leila Godfrey, Eva P. Galiza, Sarah Williams, Andrew J. Pollard, Saul N. Faust, Grace Li, Mwila Kasanyinga, Nicola Howell, Aabidah Ali, Daisy Harrison, Thomas C. Darton, Samiullah Seddiqi, David J. Kerr, Gertraud Morshead, Rachael Drake-Brockman, Aline Linder, Jamie Fowler, Sandra Belij-Rammerstorfer, Susana Camara, Colin W. Larkworthy, Sophie Davies, Marion E. Watson, Parvinder K. Aley, Bryn Horsington, Sean C. Elias, Adam J. Ritchie, Nelly Owino, David Pulido-Gomez, Michelle Fuskova, Alastair McGregor, Hannah Robinson, Fei Long, Rachel Anslow, Karen J. Ford, Daniela M. Ferreira, Katherine R. W. Emary, Ella Morey, Amy Flaxman, Paul T. Heath, Katrina M Pollock, Liliana Cifuentes Gutierrez, Samuel Provstgaard-Morys, Arabella Stuart, Helen Sanders, Anna Szigeti, Rachel White, Francesca R. Donnellan, Catherine M. Green, Katherine Sanders, N G Marchevsky, Andrea M. Collins, Merryn Voysey, Kushalinii Hillson, Teresa Lambe, Philomena Mweu, Chris Williams, Iason Vichos, Daniel B. Wright, Carina Citra Dewi Joe, Tesfaye Demissie, Rose Trivett, Richard Morter, Helen Hill, Judith Davies, Emily A. Lees, Nisha Singh, Ana Gibertoni Cruz, P Cicconi, Abigail Platt, Fernando Ramos Lopez, Nguyen Tran, and group, Oxford COVID Vaccine Trial
- Subjects
Adult ,Male ,medicine.medical_specialty ,COVID-19 Vaccines ,Time Factors ,Coronavirus disease 2019 (COVID-19) ,VACCINE ,law.invention ,Medicine, General & Internal ,Immunogenicity, Vaccine ,Randomized controlled trial ,law ,Internal medicine ,ChAdOx1 nCoV-19 ,General & Internal Medicine ,medicine ,Humans ,11 Medical and Health Sciences ,Randomized Controlled Trials as Topic ,Reactogenicity ,Science & Technology ,business.industry ,Immunogenicity ,Comment ,Vaccination ,General Medicine ,Middle Aged ,Engineering and Physical Sciences ,United Kingdom ,Oxford COVID Vaccine Trial group ,Clinical research ,Cohort ,Leukocytes, Mononuclear ,Female ,business ,Life Sciences & Biomedicine - Abstract
Background COVID-19 vaccine supply shortages are causing concerns about compromised immunity in some countries as the interval between the first and second dose becomes longer. Conversely, countries with no supply constraints are considering administering a third dose. We assessed the persistence of immunogenicity after a single dose of ChAdOx1 nCoV-19 (AZD1222), immunity after an extended interval (44–45 weeks) between the first and second dose, and response to a third dose as a booster given 28–38 weeks after the second dose. Methods In this substudy, volunteers aged 18–55 years who were enrolled in the phase 1/2 (COV001) controlled trial in the UK and had received either a single dose or two doses of 5 × 1010 viral particles were invited back for vaccination. Here we report the reactogenicity and immunogenicity of a delayed second dose (44–45 weeks after first dose) or a third dose of the vaccine (28–38 weeks after second dose). Data from volunteers aged 18–55 years who were enrolled in either the phase 1/2 (COV001) or phase 2/3 (COV002), single-blinded, randomised controlled trials of ChAdOx1 nCoV-19 and who had previously received a single dose or two doses of 5 × 1010 viral particles are used for comparison purposes. COV001 is registered with ClinicalTrials.gov, NCT04324606, and ISRCTN, 15281137, and COV002 is registered with ClinicalTrials.gov, NCT04400838, and ISRCTN, 15281137, and both are continuing but not recruiting. Findings Between March 11 and 21, 2021, 90 participants were enrolled in the third-dose boost substudy, of whom 80 (89%) were assessable for reactogenicity, 75 (83%) were assessable for evaluation of antibodies, and 15 (17%) were assessable for T-cells responses. The two-dose cohort comprised 321 participants who had reactogenicity data (with prime-boost interval of 8–12 weeks: 267 [83%] of 321; 15–25 weeks: 24 [7%]; or 44–45 weeks: 30 [9%]) and 261 who had immunogenicity data (interval of 8–12 weeks: 115 [44%] of 261; 15–25 weeks: 116 [44%]; and 44–45 weeks: 30 [11%]). 480 participants from the single-dose cohort were assessable for immunogenicity up to 44–45 weeks after vaccination. Antibody titres after a single dose measured approximately 320 days after vaccination remained higher than the titres measured at baseline (geometric mean titre of 66·00 ELISA units [EUs; 95% CI 47·83–91·08] vs 1·75 EUs [1·60–1·93]). 32 participants received a late second dose of vaccine 44–45 weeks after the first dose, of whom 30 were included in immunogenicity and reactogenicity analyses. Antibody titres were higher 28 days after vaccination in those with a longer interval between first and second dose than for those with a short interval (median total IgG titre: 923 EUs [IQR 525–1764] with an 8–12 week interval; 1860 EUs [917–4934] with a 15–25 week interval; and 3738 EUs [1824–6625] with a 44–45 week interval). Among participants who received a third dose of vaccine, antibody titres (measured in 73 [81%] participants for whom samples were available) were significantly higher 28 days after a third dose (median total IgG titre: 3746 EUs [IQR 2047–6420]) than 28 days after a second dose (median 1792 EUs [IQR 899–4634]; Wilcoxon signed rank test p=0·0043). T-cell responses were also boosted after a third dose (median response increased from 200 spot forming units [SFUs] per million peripheral blood mononuclear cells [PBMCs; IQR 127–389] immediately before the third dose to 399 SFUs per milion PBMCs [314–662] by day 28 after the third dose; Wilcoxon signed rank test p=0·012). Reactogenicity after a late second dose or a third dose was lower than reactogenicity after a first dose. Interpretation An extended interval before the second dose of ChAdOx1 nCoV-19 leads to increased antibody titres. A third dose of ChAdOx1 nCoV-19 induces antibodies to a level that correlates with high efficacy after second dose and boosts T-cell responses. Funding UK Research and Innovation, Engineering and Physical Sciences Research Council, National Institute for Health Research, Coalition for Epidemic Preparedness Innovations, National Institute for Health Research Oxford Biomedical Research Centre, Chinese Academy of Medical Sciences Innovation Fund for Medical Science, Thames Valley and South Midlands NIHR Clinical Research Network, AstraZeneca, and Wellcome.
- Published
- 2021
40. Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies
- Author
-
Kazutoyo Miura, David Pulido, Alex S. Huber, Simon J. Draper, Alexandra C. Willcox, Angela M. Minassian, Mahamadou Diakite, Lloyd D.W. King, Daniel G. W. Alanine, Jordan R. Barrett, Carole A. Long, Ababacar Diouf, and Sarah E. Silk
- Subjects
Adult ,Male ,Adolescent ,medicine.drug_class ,Plasmodium falciparum ,Antibodies, Protozoan ,Monoclonal antibody ,Mali ,General Biochemistry, Genetics and Molecular Biology ,Article ,blood stage ,growth inhibition assay ,Antimalarials ,Young Adult ,vaccine ,parasitic diseases ,Malaria Vaccines ,medicine ,Humans ,Binding site ,Apical membrane antigen 1 ,Malaria, Falciparum ,Child ,Aged ,biology ,Vaccination ,Antibody titer ,Antibodies, Monoclonal ,Infant ,antibody interaction ,Middle Aged ,biology.organism_classification ,Virology ,Antibodies, Neutralizing ,RH5 ,Polyclonal antibodies ,Child, Preschool ,Immunoglobulin G ,biology.protein ,Female ,Antibody - Abstract
Summary Reticulocyte-binding protein homolog 5 (RH5) is a leading Plasmodium falciparum blood-stage vaccine candidate. Another possible candidate, apical membrane antigen 1 (AMA1), was not efficacious in malaria-endemic populations, likely due to pre-existing antimalarial antibodies that interfered with the activity of vaccine-induced AMA1 antibodies, as judged by in vitro growth inhibition assay (GIA). To determine how pre-existing antibodies interact with vaccine-induced RH5 antibodies, we purify total and RH5-specific immunoglobulin Gs (IgGs) from malaria-exposed Malians and malaria-naive RH5 vaccinees. Infection-induced RH5 antibody titers are much lower than those induced by vaccination, and RH5-specific IgGs show differences in the binding site between the two populations. In GIA, Malian polyclonal IgGs show additive or synergistic interactions with RH5 human monoclonal antibodies and overall additive interactions with vaccine-induced polyclonal RH5 IgGs. These results suggest that pre-existing antibodies will interact favorably with vaccine-induced RH5 antibodies, in contrast to AMA1 antibodies. This study supports RH5 vaccine trials in malaria-endemic regions., Graphical abstract, Highlights RH5 IgG titers induced by infection are lower than those induced by RH5 vaccination Infection- and vaccine-induced RH5 IgGs have different specificity and avidity Infection- and vaccine-induced RH5 IgGs interact differently with RH5 mAbs Infection-induced IgGs generally do not reduce the activity of vaccine-induced IgGs, Willcox et al. combine antibodies from malaria-exposed Malians and volunteers who received a reticulocyte-binding protein homolog 5 (RH5) vaccine. In P. falciparum growth inhibition assays, infection-induced IgGs generally do not reduce the neutralizing activity of vaccine-induced IgGs. These results suggest that RH5 vaccines will induce effective antibodies in malaria-endemic populations.
- Published
- 2021
41. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study
- Author
-
Canadian Institutes of Health Research, Canada Research Chairs, Australian Lions Childhood Cancer Research Foundation, Junta de Andalucía, Asociación Española de Pediatría, Khan, Sara, Solano-Paez, Palma, Suwal, Tannu, Lu, Mei, Al-Karmi, Salma, Ho, Ben, Mumal, Iqra, Shago, Mary, Hoffman, Lindsey M., Dodgshun, Andrew, Nobusawa, Sumihito, Tabori, Uri, Bartels, Ute, Ziegler, David S., Hansford, Jordan R., Ramaswamy, Vijay, Hawkins, Cynthia, Dufour, Christelle, André, Nicolas, Bouffet, Eric, Huang, Annie, Canadian Institutes of Health Research, Canada Research Chairs, Australian Lions Childhood Cancer Research Foundation, Junta de Andalucía, Asociación Española de Pediatría, Khan, Sara, Solano-Paez, Palma, Suwal, Tannu, Lu, Mei, Al-Karmi, Salma, Ho, Ben, Mumal, Iqra, Shago, Mary, Hoffman, Lindsey M., Dodgshun, Andrew, Nobusawa, Sumihito, Tabori, Uri, Bartels, Ute, Ziegler, David S., Hansford, Jordan R., Ramaswamy, Vijay, Hawkins, Cynthia, Dufour, Christelle, André, Nicolas, Bouffet, Eric, and Huang, Annie
- Abstract
[Background] Embryonal tumours with multi-layered rosettes (ETMRs) are a newly recognised, rare paediatric brain tumour with alterations of the C19MC microRNA locus. Due to varied diagnostic practices and scarce clinical data, disease features and determinants of outcomes for these tumours are poorly defined. We did an integrated clinicopathological and molecular analysis of primary ETMRs to define clinical phenotypes, and to identify prognostic factors of survival and key treatment modalities for this orphan disease., [Methods] Paediatric patients with primary ETMRs and tissue available for analyses were identified from the Rare Brain Tumor Consortium global registry. The institutional histopathological diagnoses were centrally re-reviewed as per the current WHO CNS tumour guidelines, using histopathological and molecular assays. Only patients with complete clinical, treatment, and survival data on Nov 30, 2019, were included in clinicopathological analyses. Among patients who received primary multi-modal curative regimens, event-free survival and overall survival were determined using Cox proportional hazard and log-rank analyses. Univariate and multivariable Cox proportional hazard regression was used to estimate hazard ratios (HRs) with 95% CIs for clinical, molecular, or treatment-related prognostic factors., [Findings] 159 patients had a confirmed molecular diagnosis of primary ETMRs (median age at diagnosis 26 months, IQR 18–36) and were included in our clinicopathological analysis. ETMRs were predominantly non-metastatic (94 [73%] of 128 patients), arising from multiple sites; 84 (55%) of 154 were cerebral tumours and 70 (45%) of 154 arose at sites characteristic of other brain tumours. Hallmark C19MC alterations were seen in 144 (91%) of 159 patients; 15 (9%) were ETMR not otherwise specified. In patients treated with curative intent, event-free survival was 57% (95% CI 47–68) at 6 months and 31% (21–42) at 2 years; overall survival was 29% (20–38) at 2 years and 27% (18–37) at 4 years. Overall survival was associated with non-metastatic disease (HR 0·48, 95% CI 0·28–0·80; p=0·0057) and non-brainstem location (0·42 [0·22–0·81]; p=0·013) on univariate analysis, as well as with gross total resection (0·30, 0·16–0·58; p=0·0014), high-dose chemotherapy (0·35, 0·19–0·67; p=0·0020), and radiotherapy (0·21, 0·10–0·41; p<0·0001) on multivariable analysis. 2-year event-free and overall survival was 0% at 2 years in patients treated with conventional chemotherapy without radiotherapy (regardless of surgery extent), and 21% (95% CI 1–41) and 30% (6–54), respectively, in patients treated with high-dose chemotherapy, and gross total resection without radiotherapy. 2-year event-free survival in patients treated with high-dose chemotherapy and radiotherapy was 66% (95% CI 39–93) for patients with gross total resection and 44% (7–81) for patients with sub-total resection. 2–5-year overall survival was 66% (95% CI 33–99, p=0·038) for patients with gross total resection and 67% (36–98, p=0·0020) for patients with sub-total resection., [Interpretation] Prompt molecular diagnosis and post-surgical treatment with intensive multi-modal therapy tailored to patient-specific risk features could improve ETMR survival.
- Published
- 2021
42. Thermodynamic Surface Analyses to Inform Biofilm Resistance
- Author
-
Pooja R. Patel, Rebecca Ann Herrington Faulkner, Verena N. Ghebranious, Emily B. Henry, Charles J. Holt, Alexandra R. Dodds, Jasmine G. Carlisle, D. Spencer Oskin, Jacob A. Lowry, Devin Smith, T. Brian Cavitt, Phillip R. Hendley, Tyson C. Garfield, Wenting Wei, and Jordan R. Lowe
- Subjects
0301 basic medicine ,02 engineering and technology ,Microbiology ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Microscopy ,lcsh:Science ,Acrylate ,Multidisciplinary ,biology ,Chemistry ,Biofilm ,Substrate (chemistry) ,021001 nanoscience & nanotechnology ,biology.organism_classification ,Polymer Chemistry ,Surface energy ,030104 developmental biology ,Monomer ,Chemical engineering ,Polymerization ,Thermodynamics ,lcsh:Q ,0210 nano-technology ,Bacteria - Abstract
Summary Biofilms are the habitat of 95% of bacteria successfully protecting bacteria from many antibiotics. However, inhibiting biofilm formation is difficult in that it is a complex system involving the physical and chemical interaction of both substrate and bacteria. Focusing on the substrate surface and potential interactions with bacteria, we examined both physical and chemical properties of substrates coated with a series of phenyl acrylate monomer derivatives. Atomic force microscopy (AFM) showed smooth surfaces often approximating surgical grade steel. Induced biofilm growth of five separate bacteria on copolymer samples comprising varying concentrations of phenyl acrylate monomer derivatives evidenced differing degrees of biofilm resistance via optical microscopy. Using goniometric surface analyses, the van Oss-Chaudhury-Good equation was solved linear algebraically to determine the surface energy profile of each polymerized phenyl acrylate monomer derivative, two bacteria, and collagen. Based on the microscopy and surface energy profiles, a thermodynamic explanation for biofilm resistance is posited., Graphical Abstract, Highlights • Surface energy components affect bacterial adhesion to substrates • Bacterial adhesion is directly related to the substrate's polar component • Bacterial adhesion is inversely related to the substrate's base component • Polarizable substrates may allow bacterial association, and not adhesion, Polymer Chemistry; Thermodynamics; Microbiology
- Published
- 2020
43. Structural and vibrational behavior of cubic Cu1.80(3)Se cuprous selenide, berzelianite, under compression
- Author
-
Universitat Politècnica de València. Departamento de Física Aplicada - Departament de Física Aplicada, Generalitat Valenciana, ALBA Synchrotron Light Source, AGENCIA ESTATAL DE INVESTIGACION, Agencia Estatal de Investigación, Ministerio de Economía y Competitividad, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brasil, Chulia-Jordan, R., Santamaria-Perez, D., Pereira, A. L. J., Garcia-Domene, B., Vilaplana Cerda, Rosario Isabel, Sans-Tresserras, Juan Ángel, Martinez-Garcia, D., Morales-Garcia, A., Popescu, C., Muehle, C., Jansen, M., Manjón, Francisco-Javier, Universitat Politècnica de València. Departamento de Física Aplicada - Departament de Física Aplicada, Generalitat Valenciana, ALBA Synchrotron Light Source, AGENCIA ESTATAL DE INVESTIGACION, Agencia Estatal de Investigación, Ministerio de Economía y Competitividad, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brasil, Chulia-Jordan, R., Santamaria-Perez, D., Pereira, A. L. J., Garcia-Domene, B., Vilaplana Cerda, Rosario Isabel, Sans-Tresserras, Juan Ángel, Martinez-Garcia, D., Morales-Garcia, A., Popescu, C., Muehle, C., Jansen, M., and Manjón, Francisco-Javier
- Abstract
[EN] We have performed an experimental study of the crystal structure and lattice dynamics of cubic Cu1.80(3)Se at ambient temperature and high pressures. Two reversible phase transitions were found at 2.9 and 8.7 GPa. The indexation of the angle-dispersive synchrotron x-ray diffraction patterns suggests a large orthorhombic cell and a monoclinic cell for the high-pressure phases. Raman measurements provide additional information on the local structure. The compressibility of the three ambient temperature phases has been determined and compared to that of other sulphides and selenides.
- Published
- 2020
44. Bean Common Mosaic Virus and Bean Common Mosaic Necrosis Virus
- Author
-
Jordan, R., primary and Hammond, J., additional
- Published
- 2008
- Full Text
- View/download PDF
45. List of contributors
- Author
-
Jennifer Adams, Sanjiv Agarwal, Imtiaz Ahmad, Sameer K. Akolkar, Anthony L. Almada, Rend Al-Mondhiry, Okezie I. Aruoma, Debasis Bagchi, Theeshan Bahorun, Jordan R. Bailey, Kiran Bhupathiraju, Katie Bond, George A. Burdock, Ioana G. Carabin, Alessia Cavaliere, Digambar Chahar, Pradip Chakraborty, Jayson Chen, Gregory J. Chinlund, Leighton K. Chong, Patrick Coppens, Willette M. Crawford, Amitava Das, Praneel Datla, Cristian Del Bo’, Bernard W. Downs, Meggan F. Duffy, Asim K. Duttaroy, Matthew Farrell, Thomas Frey, Dilip Ghosh, Nandini Ghosh, Trimurtulu Golakoti, Raghavendra Gowda, James C. Griffiths, Neelam Gulati, Om P. Gulati, John R. Harrison, Michael Harvey, James E. Hoadley, Stein Hordvik, Chun Hu, Hideko Ikeda, Michelle C. Jackson, Urmila Jarouliya, Sam Jennings, Sewon Jeong, Danielle K. Johnson, Raj K. Keservani, Ji Yeon Kim, Seong Ju Kim, Alla A. Kochetkova, Alluri V. Krishnaraju, Lisa Glymph Lattimore, Teck-Chai Lau, Claudia A. Lewis, Daniela Martini, Nikita McGee, Colleen McMullin, Odete Mendes, Sandra Morar, Hiroyoshi Moriyama, Chelsea M. Murray, Vidushi S. Neergheen-Bhujun, Haiuyen Nguyen, Hirobumi Ohama, Peter Berry Ottaway, Tobey-Ann Pinder, Jon-Paul Powers, Rabbi Gavriel Price, Jennifer Radosevich, Nancy E. Rawson, Joe M. Regenstein, Lewis Retik, Chandan K. Sen, Krishanu Sengupta, Andrew Shao, Anil K. Sharma, Jeffrey S. Sharp, Julia Shenkar, Svetlana A. Sheveleva, Makoto Shimizu, Elena A. Smirnova, Boris P. Sukhanov, Anand Swaroop, Izabela Tańska, John Travis, Victor A. Tutelyan, Lawrence J. Udell, Jessica White, and Jerzy Zawistowski
- Published
- 2019
- Full Text
- View/download PDF
46. A C19MC-LIN28A-MYCN oncogenic circuit driven by hijacked super-enhancers is a distinct therapeutic vulnerability in ETMRs: A lethal brain tumor
- Author
-
Irtisha Singh, Stephen C. Mack, Dalia Barsyte-Lovejoy, Sarah Leary, Alyssa Reddy, Daniel Catchpoole, Yin Wang, Patrick Sin-Chan, Tannu Suwal, Cynthia Hawkins, Jean M. Mulcahy Levy, Jennifer A. Chan, Tai Tong Wong, Jean Michaud, Iqra Mumal, Charles Y. Lin, Timothy E. Van Meter, Eugene Hwang, Maryam Fouladi, Xiao-Nan Li, Dean Popovski, Palma Solano-Paez, Luca Massimi, Eloy Rivas, Hideo Nakamura, Richard Grundy, Ben Ho, Mei Lu, Ramya Ramanujachar, Peter B. Dirks, Alvaro Lassaletta, Lucie Lafay-Cousin, Sheila K. Singh, Eric Bouffet, Paul Guilhamon, Young Shin Ra, G. Yancey Gillespie, Michael D. Taylor, Claudia L. Kleinman, Nalin Gupta, Benjamin Ellezam, Nada Jabado, Annie Huang, Jeremy N. Rich, Yuchen Du, Jonathon Torchia, Holly Lindsay, Neilket Patel, Xiaolian Fan, Jordan R. Hansford, Lindsey M. Hoffman, Seung-Ki Kim, Jason Fangusaro, Donna L. Johnston, and Canadian Institutes of Health Research
- Subjects
0301 basic medicine ,Cancer Research ,LIN28A ,Settore MED/27 - NEUROCHIRURGIA ,Gene regulatory network ,Cell Transformation ,Epigenesis, Genetic ,0302 clinical medicine ,Super-enhancer ,Cell-cycleepigenetics ,Models ,Neoplasms ,MYCN ,therapeutics ,Gene Regulatory Networks ,Cancer ,Regulation of gene expression ,N-Myc Proto-Oncogene Protein ,Tumor ,microRNA ,Brain Neoplasms ,Cell Cycle ,RNA-Binding Proteins ,Cell cycle ,Neoplasms, Germ Cell and Embryonal ,C19MC ,3. Good health ,Cell Transformation, Neoplastic ,Enhancer Elements, Genetic ,Oncology ,5.1 Pharmaceuticals ,030220 oncology & carcinogenesis ,Chromosomes, Human, Pair 2 ,Multigene Family ,Pair 2 ,Development of treatments and therapeutic interventions ,brain tumor ,Human ,Biotechnology ,Enhancer Elements ,DNA Copy Number Variations ,Oncology and Carcinogenesis ,Therapeutics ,Biology ,Models, Biological ,Brain tumors ,Chromosomes ,03 medical and health sciences ,Rare Diseases ,Genetic ,super-enhancer ,Biomarkers, Tumor ,Genetics ,Humans ,Genetic Predisposition to Disease ,Epigenetics ,Oncology & Carcinogenesis ,neoplasms ,Genetic Association Studies ,Neoplastic ,Pair 19 ,epigenetics ,Neurosciences ,Cell Biology ,Oncogenes ,Biological ,Bromodomain ,ETMR ,MicroRNAs ,030104 developmental biology ,Gene Expression Regulation ,cell-cycle ,Cancer research ,Germ Cell and Embryonal ,Chromosomes, Human, Pair 19 ,Biomarkers ,Epigenesis - Abstract
Embryonal tumors with multilayered rosettes (ETMRs) are highly lethal infant brain cancers with characteristic amplification of Chr19q13.41 miRNA cluster (C19MC) and enrichment of pluripotency factor LIN28A. Here we investigated C19MC oncogenic mechanisms and discovered a C19MC-LIN28A-MYCN circuit fueled by multiple complex regulatory loops including an MYCN core transcriptional network and super-enhancers resulting from long-range MYCN DNA interactions and C19MC gene fusions. Our data show that this powerful oncogenic circuit, which entraps an early neural lineage network, is potently abrogated by bromodomain inhibitor JQ1, leading to ETMR cell death., This project was funded by a Canadian Institutes of Health Research (CIHR) grant no. 137011 and b.r.a.i.n. child to A.H. T.S. is a CIHR Scholar.
- Published
- 2019
47. Understanding medical foods under FDA regulations
- Author
-
Claudia A. Lewis, Michelle C. Jackson, and Jordan R. Bailey
- Published
- 2019
- Full Text
- View/download PDF
48. A C19MC-LIN28A-MYCN oncogenic circuit driven by hijacked super-enhancers is a distinct therapeutic vulnerability in ETMRs: A lethal brain tumor
- Author
-
Canadian Institutes of Health Research, Sin-Chan, Patrick, Mumal, Iqra, Suwal, Tannu, Ho, Ben, Fan, Xiaolian, Singh, Irtisha, Du, Yuchen, Lu, Mei, Patel, Neilket, Torchia, Jonathon, Popovski, Dean, Fouladi, Maryam, Guilhamon, Paul, Hansford, Jordan R., Leary, Sarah, Hoffman, Lindsey M., Levy, Jean M. Mulcahy, Lassaletta, Alvaro, Solano-Paez, Palma, Rivas Infante, Eloy, Reddy, Alyssa, Gillespie, G. Yancey, Gupta, Nalin, Van Meter, Timothy E., Nakamura, Hideo, Wong, Tai-Tong, Ra, Young-Shin, Kim, Seung-Ki, Massimi, Luca, Grundy, Richard G., Fangusaro, Jason, Johnston, Donna, Chan, Jennifer, Lafay-Cousin, Lucie, Hwang, Eugene I., Wang, Yin, Catchpoole, Daniel, Michaud, Jean, Ellezam, Benjamin, Ramanujachar, Ramya, Lindsay, Holly, Taylor, Michael D., Hawkins, Cynthia, Bouffet, Eric, Jabado, Nada, Singh, Sheila K., Kleinman, Claudia L., Barsyte-Lovejoy, Dalia, Li, Xiao-Nan, Dirks, Peter B., Lin, Charles Y., Mack, Stephen C., Rich, Jeremy N., Huang, Annie, Canadian Institutes of Health Research, Sin-Chan, Patrick, Mumal, Iqra, Suwal, Tannu, Ho, Ben, Fan, Xiaolian, Singh, Irtisha, Du, Yuchen, Lu, Mei, Patel, Neilket, Torchia, Jonathon, Popovski, Dean, Fouladi, Maryam, Guilhamon, Paul, Hansford, Jordan R., Leary, Sarah, Hoffman, Lindsey M., Levy, Jean M. Mulcahy, Lassaletta, Alvaro, Solano-Paez, Palma, Rivas Infante, Eloy, Reddy, Alyssa, Gillespie, G. Yancey, Gupta, Nalin, Van Meter, Timothy E., Nakamura, Hideo, Wong, Tai-Tong, Ra, Young-Shin, Kim, Seung-Ki, Massimi, Luca, Grundy, Richard G., Fangusaro, Jason, Johnston, Donna, Chan, Jennifer, Lafay-Cousin, Lucie, Hwang, Eugene I., Wang, Yin, Catchpoole, Daniel, Michaud, Jean, Ellezam, Benjamin, Ramanujachar, Ramya, Lindsay, Holly, Taylor, Michael D., Hawkins, Cynthia, Bouffet, Eric, Jabado, Nada, Singh, Sheila K., Kleinman, Claudia L., Barsyte-Lovejoy, Dalia, Li, Xiao-Nan, Dirks, Peter B., Lin, Charles Y., Mack, Stephen C., Rich, Jeremy N., and Huang, Annie
- Abstract
Embryonal tumors with multilayered rosettes (ETMRs) are highly lethal infant brain cancers with characteristic amplification of Chr19q13.41 miRNA cluster (C19MC) and enrichment of pluripotency factor LIN28A. Here we investigated C19MC oncogenic mechanisms and discovered a C19MC-LIN28A-MYCN circuit fueled by multiple complex regulatory loops including an MYCN core transcriptional network and super-enhancers resulting from long-range MYCN DNA interactions and C19MC gene fusions. Our data show that this powerful oncogenic circuit, which entraps an early neural lineage network, is potently abrogated by bromodomain inhibitor JQ1, leading to ETMR cell death.
- Published
- 2019
49. Tools and methods in participatory modeling: Selecting the right tool for the job
- Author
-
Voinov, A., Jenni, K., Gray, S., Kolagani, N., Glynn, P.D., Bommel, P., Prell, C., Zellner, M., Paolisso, M., Jordan, R., Sterling, E., Schmitt Olabisi, L., Giabbanelli, P.J., Sun, Z., Le Page, C., Elsawah, S., BenDor, T.K., Hubacek, K., Laursen, B.K., Jetter, A., Basco-Carrera, L., Singer, A., Young, L., Brunacini, J., Smajgl, A., Voinov, A., Jenni, K., Gray, S., Kolagani, N., Glynn, P.D., Bommel, P., Prell, C., Zellner, M., Paolisso, M., Jordan, R., Sterling, E., Schmitt Olabisi, L., Giabbanelli, P.J., Sun, Z., Le Page, C., Elsawah, S., BenDor, T.K., Hubacek, K., Laursen, B.K., Jetter, A., Basco-Carrera, L., Singer, A., Young, L., Brunacini, J., and Smajgl, A.
- Abstract
Various tools and methods are used in participatory modelling, at different stages of the process and for different purposes. The diversity of tools and methods can create challenges for stakeholders and modelers when selecting the ones most appropriate for their projects. We offer a systematic overview, assessment, and categorization of methods to assist modelers and stakeholders with their choices and decisions. Most available literature provides little justification or information on the reasons for the use of particular methods or tools in a given study. In most of the cases, it seems that the prior experience and skills of the modelers had a dominant effect on the selection of the methods used. While we have not found any real evidence of this approach being wrong, we do think that putting more thought into the method selection process and choosing the most appropriate method for the project can produce better results. Based on expert opinion and a survey of modelers engaged in participatory processes, we offer practical guidelines to improve decisions about method selection at different stages of the participatory modeling process.
- Published
- 2018
50. Molecular Beam Epitaxy of Nitrides for Advanced Electronic Materials
- Author
-
Jordan R. Lang, Gregor Koblmüller, E.C. Young, and James S. Speck
- Subjects
chemistry.chemical_compound ,Materials science ,chemistry ,business.industry ,Optoelectronics ,Crystal growth ,Gallium nitride ,Active nitrogen ,High-electron-mobility transistor ,Nitride ,business ,Electronic materials ,Molecular beam epitaxy - Abstract
In this chapter, we give a brief historical overview of developments in the growth of gallium nitride films by molecular beam epitaxy (MBE). Active nitrogen for GaN film growth can be supplied either by plasma-assisted MBE or ammonia-assisted MBE, and a description of equipment and procedures is given for both techniques. Growth regimes for both techniques have been well established, and in general plasma-assisted MBE is practiced in a metal-rich growth regime, and ammonia-MBE is practiced in a nitrogen-rich growth regime. We review the growth regimes and growth methods for achieving high structural and electronic quality gallium nitride and related alloys (In,Al,GaN) for advanced electronic and optoelectronic devices.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.